{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T20:07:55Z","timestamp":1774555675854,"version":"3.50.1"},"reference-count":237,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12602-021-09776-6","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T21:44:51Z","timestamp":1616103891000},"page":"926-948","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Mechanisms of Candida\u00a0Resistance to Antimycotics and Promising Ways to Overcome It: The Role of Probiotics"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1853-0475","authenticated-orcid":false,"given":"Konstantin A.","family":"Demin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1856-4069","authenticated-orcid":false,"given":"Aleksandr G.","family":"Refeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6497-1648","authenticated-orcid":false,"given":"Anna A.","family":"Bogdanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7823-9044","authenticated-orcid":false,"given":"Evgenya V.","family":"Prazdnova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-8731","authenticated-orcid":false,"given":"Igor V.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7452-6994","authenticated-orcid":false,"given":"Olga Yu.","family":"Kutsevalova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9834-3989","authenticated-orcid":false,"given":"Alexey M.","family":"Ermakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7452-6203","authenticated-orcid":false,"given":"Anzhelica B.","family":"Bren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1916-8570","authenticated-orcid":false,"given":"Dmitry V.","family":"Rudoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-0855","authenticated-orcid":false,"given":"Vladimir A.","family":"Chistyakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Weeks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7265-4562","authenticated-orcid":false,"given":"Michael L.","family":"Chikindas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"issue":"9","key":"9776_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1398-9995.1994.tb02102.x","volume":"49","author":"K Akiyama","year":"1994","unstructured":"Akiyama K, Shida T, Yasueda H, Mita H, Yamamoto T, Yamaguchi H (1994) Atopic asthma caused by Candida albicans acid protease: case reports. Allergy 49(9):778\u2013781. https:\/\/doi.org\/10.1111\/j.1398-9995.1994.tb02102.x","journal-title":"Allergy"},{"issue":"12","key":"9776_CR2","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17(12):e383\u2013e392. https:\/\/doi.org\/10.1016\/S1473-3099(17)30316-X","journal-title":"Lancet Infect Dis"},{"issue":"1411","key":"9776_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1098\/rstb.2001.0888","volume":"356","author":"LH Taylor","year":"2001","unstructured":"Taylor LH, Latham SM, Woolhouse ME (2001) Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 356(1411):983\u2013989. https:\/\/doi.org\/10.1098\/rstb.2001.0888","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"9776_CR4","doi-asserted-by":"publisher","unstructured":"Casadevall A, Kontoyiannis DP, Robert V (2019) On the emergence of Candida auris: climate change, azoles, swamps, and birds. mBio 10(4):e01397\u201319.\u00a0https:\/\/doi.org\/10.1128\/mBio.01397-19","DOI":"10.1128\/mBio.01397-19"},{"key":"9776_CR5","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2147\/IDR.S124918","volume":"10","author":"NP Wiederhold","year":"2017","unstructured":"Wiederhold NP (2017) Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist 10:249\u2013259. https:\/\/doi.org\/10.2147\/IDR.S124918","journal-title":"Infect Drug Resist"},{"issue":"6","key":"9776_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41579-019-0322-2","volume":"18","author":"J Berman","year":"2020","unstructured":"Berman J, Krysan DJ (2020) Drug resistance and tolerance in fungi. Nat Rev Microbiol 18(6):319\u2013331. https:\/\/doi.org\/10.1038\/s41579-019-0322-2","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"9776_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/aac.32.1.1","volume":"32","author":"MS Saag","year":"1988","unstructured":"Saag MS, Dismukes WE (1988) Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother 32(1):1\u20138. https:\/\/doi.org\/10.1128\/aac.32.1.1","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"9776_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/genes9090461","volume":"9","author":"E Ksiezopolska","year":"2018","unstructured":"Ksiezopolska E, Gabald\u00f3n T (2018) Evolutionary emergence of drug resistance in Candida opportunistic pathogens. Genes (Basel) 9(9):461. https:\/\/doi.org\/10.3390\/genes9090461","journal-title":"Genes (Basel)"},{"key":"9776_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/IDR.S118892","volume":"10","author":"EL Berkow","year":"2017","unstructured":"Berkow EL, Lockhart SR (2017) Fluconazole resistance in Candida species: a current perspective. Infect Drug Resist 10:237\u2013245. https:\/\/doi.org\/10.2147\/IDR.S118892","journal-title":"Infect Drug Resist"},{"key":"9776_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/IDR.S116229","volume":"10","author":"S Sarma","year":"2017","unstructured":"Sarma S, Upadhyay S (2017) Current perspective on emergence, diagnosis and drug resistance in Candida auris. Infect Drug Resist 10:155\u2013165. https:\/\/doi.org\/10.2147\/IDR.S116229","journal-title":"Infect Drug Resist"},{"key":"9776_CR11","doi-asserted-by":"publisher","unstructured":"Lee Y, Puumala E, Robbins N, Cowen LE (2020) Antifungal drug resistance: molecular mechanisms in Candida albicans and beyond. Chem Rev.\u00a0https:\/\/doi.org\/10.1021\/acs.chemrev.0c00199\u00a0[Epub ahead of print]","DOI":"10.1021\/acs.chemrev.0c00199"},{"key":"9776_CR12","doi-asserted-by":"publisher","unstructured":"Krishnasamy L, Krishnakumar S, Kumaramanickavel G, Saikumar C (2018) Molecular mechanisms of antifungal drug resistance in Candida species. J Clin Diagnostic Res 12(9):DE01\u2013DE06. https:\/\/doi.org\/10.7860\/JCDR\/2018\/36218.11961","DOI":"10.7860\/JCDR\/2018\/36218.11961"},{"issue":"6","key":"9776_CR13","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3390\/antibiotics9060312","volume":"9","author":"S Bhattacharya","year":"2020","unstructured":"Bhattacharya S, Sae-Tia S, Fries BC (2020) Candidiasis and mechanisms of antifungal resistance. Antibiotics (Basel) 9(6):312. https:\/\/doi.org\/10.3390\/antibiotics9060312","journal-title":"Antibiotics (Basel)"},{"issue":"9","key":"9776_CR14","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/cid\/ciw038","volume":"62","author":"VH Matsubara","year":"2016","unstructured":"Matsubara VH, Bandara HM, Mayer MP, Samaranayake LP (2016) Probiotics as antifungals in mucosal candidiasis. Clin Infect Dis 62(9):1143\u20131153. https:\/\/doi.org\/10.1093\/cid\/ciw038","journal-title":"Clin Infect Dis"},{"issue":"9","key":"9776_CR15","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2174\/1568026618666180528121707","volume":"18","author":"V Srivastava","year":"2018","unstructured":"Srivastava V, Singla RK, Dubey AK (2018) Emerging virulence, drug resistance and future anti-fungal drugs for Candida pathogens. Curr Top Med Chem 18(9):759\u2013778. https:\/\/doi.org\/10.2174\/1568026618666180528121707","journal-title":"Curr Top Med Chem"},{"key":"9776_CR16","doi-asserted-by":"publisher","unstructured":"Silva MP, Rossoni RD, Junqueira JC, Jorge AOC (2016) Probiotics for prevention and treatment of candidiasis and other infectious diseases: Lactobacillus spp. and other potential bacterial species. In: Rao V (ed), Rao LG (ed) Probiotics and Prebiotics in Human Nutrition and Health, 1st edn. Intech Open Science, London, pp 241\u2013262. https:\/\/doi.org\/10.5772\/64093","DOI":"10.5772\/64093"},{"issue":"3","key":"9776_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1080\/14787210.2017.1268530","volume":"15","author":"HM Bandara","year":"2017","unstructured":"Bandara HM, Matsubara VH, Samaranayake LP (2017) Future therapies targeted towards eliminating Candida biofilms and associated infections. Expert Rev Anti Infect Ther 15(3):299\u2013318. https:\/\/doi.org\/10.1080\/14787210.2017.1268530","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"4","key":"9776_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD (2016) Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 62(4):e1\u2013e50. https:\/\/doi.org\/10.1093\/cid\/civ933","journal-title":"Clin Infect Dis"},{"issue":"4","key":"9776_CR19","doi-asserted-by":"publisher","first-page":"e02372","DOI":"10.1128\/AAC.02372-16","volume":"61","author":"J Meletiadis","year":"2017","unstructured":"Meletiadis J, Curfs-Breuker I, Meis JF, Mouton JW (2017) In vitro antifungal susceptibility testing of Candida isolates with the EUCAST methodology, a new method for ECOFF determination. Antimicrob Agents Chemother 61(4):e02372-16. https:\/\/doi.org\/10.1128\/AAC.02372-16","journal-title":"Antimicrob Agents Chemother"},{"issue":"29","key":"9776_CR20","doi-asserted-by":"publisher","first-page":"14734","DOI":"10.1073\/pnas.1906169116","volume":"116","author":"I Levin-Reisman","year":"2019","unstructured":"Levin-Reisman I, Brauner A, Ronin I, Balaban NQ (2019) Epistasis between antibiotic tolerance, persistence, and resistance mutations. Proc Natl Acad Sci U.S.A. 116(29):14734\u201314739. https:\/\/doi.org\/10.1073\/pnas.1906169116","journal-title":"Proc Natl Acad Sci U.S.A."},{"issue":"5","key":"9776_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","volume":"14","author":"A Brauner","year":"2016","unstructured":"Brauner A, Fridman O, Gefen O, Balaban NQ (2016) Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol 14(5):320\u2013330. https:\/\/doi.org\/10.1038\/nrmicro.2016.34","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"9776_CR22","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1038\/s41467-018-04926-x","volume":"9","author":"A Rosenberg","year":"2018","unstructured":"Rosenberg A, Ene IV, Bibi M, Zakin S, Segal ES, Ziv N, Dahan AM, Colombo AL, Bennett RJ, Berman J (2018) Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia. Nat Commun 9(1):2470. https:\/\/doi.org\/10.1038\/s41467-018-04926-x","journal-title":"Nat Commun"},{"issue":"2","key":"9776_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1134\/S2079086415020103","volume":"5","author":"ON Tikhodeyev","year":"2015","unstructured":"Tikhodeyev ON (2015) Crisis of the term \u201cmutation\u201d and its resolution in the context of the differential concept of variability. Biol Bull Rev 5(2):119\u2013129. https:\/\/doi.org\/10.1134\/S2079086415020103","journal-title":"Biol Bull Rev"},{"issue":"6327","key":"9776_CR24","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.aaj2191","volume":"355","author":"I Levin-Reisman","year":"2017","unstructured":"Levin-Reisman I, Ronin I, Gefen O, Braniss I, Shoresh N, Balaban NQ (2017) Antibiotic tolerance facilitates the evolution of resistance. Science 355(6327):826\u2013830. https:\/\/doi.org\/10.1126\/science.aaj2191","journal-title":"Science"},{"issue":"3","key":"9776_CR25","doi-asserted-by":"publisher","first-page":"S431","DOI":"10.1093\/infdis\/jix179","volume":"216","author":"DP Kontoyiannis","year":"2017","unstructured":"Kontoyiannis DP (2017) Antifungal resistance: an emerging reality and a global challenge. J Infect Dis 216(3):S431\u2013S435. https:\/\/doi.org\/10.1093\/infdis\/jix179","journal-title":"J Infect Dis"},{"key":"9776_CR26","doi-asserted-by":"publisher","unstructured":"Vallabhaneni S, Cleveland AA, Farley MM, Harrison LH, Schaffner W, Beldavs ZG, Derado G, Pham CD, Lockhart SR, Smith RM (2015) Epidemiology and risk factors for echinocandin nonsusceptible Candida glabrata bloodstream infections: data from a large multisite population-based candidemia surveillance program, 2008-2014. Open Forum Infect Dis 2(4):ofv163. https:\/\/doi.org\/10.1093\/ofid\/ofv163","DOI":"10.1093\/ofid\/ofv163"},{"issue":"1","key":"9776_CR27","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","volume":"6","author":"MA Pfaller","year":"2019","unstructured":"Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN (2019) Twenty years of the SENTRY antifungal surveillance program: results for Candida species from 1997\u20132016. Open Forum Infect Dis 6(1):S79\u2013S94. https:\/\/doi.org\/10.1093\/ofid\/ofy358","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"9776_CR28","doi-asserted-by":"publisher","first-page":"e449","DOI":"10.1093\/cid\/ciaa193","volume":"71","author":"SV Tsay","year":"2017","unstructured":"Tsay SV, Mu Y, Williams S, Epson E, Nadle J, Bamberg WM, Barter DM, Johnston HL, Farley MM, Harb S, Thomas S, Bonner LA, Harrison LH, Hollick R, Marceaux K, Mody RK, Pattee B, Shrum Davis S, Phipps EC, Tesini BL, Gellert AB, Zhang AY, Schaffner W, Hillis S, Ndi D, Graber CR, Jackson BR, Chiller T, Magill S (2017) Vallabhaneni S (2020) Burden of candidemia in the United States. Clin Infect Dis 71(9):e449\u2013e453. https:\/\/doi.org\/10.1093\/cid\/ciaa193","journal-title":"Clin Infect Dis"},{"issue":"9","key":"9776_CR29","doi-asserted-by":"publisher","first-page":"a019778","DOI":"10.1101\/cshperspect.a019778","volume":"4","author":"SA Turner","year":"2014","unstructured":"Turner SA, Butler G (2014) The Candida pathogenic species complex. Cold Spring Harb Perspect Med 4(9):a019778. https:\/\/doi.org\/10.1101\/cshperspect.a019778","journal-title":"Cold Spring Harb Perspect Med"},{"key":"9776_CR30","doi-asserted-by":"publisher","unstructured":"Yang B, Rao R (2019) Emerging pathogens of the Candida species. In: Sandai D (ed) Candida albicans, 1st edn, Intech Open Science, London, pp 3-18. https:\/\/doi.org\/10.5772\/intechopen.80378","DOI":"10.5772\/intechopen.80378"},{"key":"9776_CR31","unstructured":"Kutsevalova OY, Jankovskaja, GV. Astvatsaturyan EI (2014) Characteristic of pathogens of invasive candidosis. Med Mycol Probl 16:97. https:\/\/mycology.szgmu.ru\/files\/MAPO_2_2014.pdf"},{"issue":"4","key":"9776_CR32","doi-asserted-by":"publisher","first-page":"e01564","DOI":"10.1128\/JCM.01564-17","volume":"56","author":"K Astvad","year":"2018","unstructured":"Astvad K, Johansen HK, R\u00f8der BL, Rosenvinge FS, Knudsen JD, Lemming L, Sch\u00f8nheyder HC, Hare RK, Kristensen L, Nielsen L, Gertsen JB, Dzajic E, Pedersen M, \u00d8sterg\u00e5rd C, Olesen B, S\u00f8ndergaard TS, Arendrup MC (2018) Update from a 12-year nationwide fungemia surveillance: increasing intrinsic and acquired resistance causes concern. J Clin Microbiol 56(4):e01564-17. https:\/\/doi.org\/10.1128\/JCM.01564-17","journal-title":"J Clin Microbiol"},{"key":"9776_CR33","doi-asserted-by":"publisher","first-page":"18026","DOI":"10.1038\/nrdp.2018.26","volume":"4","author":"PG Pappas","year":"2018","unstructured":"Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ (2018) Invasive candidiasis. Nat Rev Dis Primers 4:18026. https:\/\/doi.org\/10.1038\/nrdp.2018.26","journal-title":"Invasive candidiasis. Nat Rev Dis Primers"},{"issue":"3","key":"9776_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10123-018-0014-1","volume":"21","author":"G Quind\u00f3s","year":"2018","unstructured":"Quind\u00f3s G, Marcos-Arias C, San-Mill\u00e1n R, Mateo E, Eraso E (2018) The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris. Int Microbiol 21(3):107\u2013119. https:\/\/doi.org\/10.1007\/s10123-018-0014-1","journal-title":"Int Microbiol."},{"issue":"5","key":"9776_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jiac.2018.09.016","volume":"25","author":"JH Ko","year":"2019","unstructured":"Ko JH, Jung DS, Lee JY, Kim HA, Ryu SY, Jung SI, Joo EJ, Cheon S, Kim YS, Kim SW, Cho SY, Kang CI, Chung DR, Lee NY, Peck KR (2019) Changing epidemiology of non-albicans candidemia in Korea. J Infect Chemother 25(5):388\u2013391. https:\/\/doi.org\/10.1016\/j.jiac.2018.09.016","journal-title":"J Infect Chemother"},{"issue":"1","key":"9776_CR36","doi-asserted-by":"publisher","first-page":"100906","DOI":"10.1016\/j.mycmed.2019.100906","volume":"30","author":"A Prigitano","year":"2020","unstructured":"Prigitano A, Cavanna C, Passera M, Gelmi M, Sala E, Ossi C, Grancini A, Calabr\u00f2 M, Bramati S, Tejada M, Lallitto F, Farina C, Rognoni V, Fasano MA, Pini B, Roman\u00f2 L, Cogliati M, Esposto MC, Tortorano AM (2020) Evolution of fungemia in an Italian region. J Mycol Med 30(1):100906. https:\/\/doi.org\/10.1016\/j.mycmed.2019.100906","journal-title":"J Mycol Med"},{"key":"9776_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.mib.2019.05.008","volume":"52","author":"J Rhodes","year":"2019","unstructured":"Rhodes J, Fisher MC (2019) Global epidemiology of emerging Candida auris. Curr Opin Microbiol 52:84\u201389. https:\/\/doi.org\/10.1016\/j.mib.2019.05.008","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"9776_CR38","doi-asserted-by":"publisher","first-page":"e0210397","DOI":"10.1371\/journal.pone.0210397","volume":"14","author":"K Spettel","year":"2019","unstructured":"Spettel K, Barousch W, Makristathis A, Zeller I, Nehr M, Selitsch B, Lackner M, Rath PM, Steinmann J, Willinger B (2019) Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing. PloS One 14(1):e0210397. https:\/\/doi.org\/10.1371\/journal.pone.0210397","journal-title":"PloS one"},{"issue":"7","key":"9776_CR39","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","volume":"25","author":"KE Pristov","year":"2019","unstructured":"Pristov KE, Ghannoum MA (2019) Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect 25(7):792\u2013798. https:\/\/doi.org\/10.1016\/j.cmi.2019.03.028","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"9776_CR40","doi-asserted-by":"publisher","first-page":"e1003550","DOI":"10.1371\/journal.ppat.1003550","volume":"9","author":"N Papon","year":"2013","unstructured":"Papon N, Courdavault V, Clastre M, Bennett RJ (2013) Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm. PLoS Pathog 9(9):e1003550. https:\/\/doi.org\/10.1371\/journal.ppat.1003550","journal-title":"PLoS Pathog"},{"issue":"3","key":"9776_CR41","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/jac\/45.3.408","volume":"45","author":"F Barchiesi","year":"2000","unstructured":"Barchiesi F, Arzeni D, Caselli F, Scalise G (2000) Primary resistance to flucytosine among clinical isolates of Candida spp. J Antimicrob Chemother 45(3):408\u2013409. https:\/\/doi.org\/10.1093\/jac\/45.3.408","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"9776_CR42","doi-asserted-by":"publisher","first-page":"e01926","DOI":"10.1128\/AAC.01926-17","volume":"62","author":"Z Khan","year":"2018","unstructured":"Khan Z, Ahmad S, Mokaddas E, Meis JF, Joseph L, Abdullah A, Vayalil S (2018) Development of echinocandin resistance in Candida tropicalis following short-term exposure to caspofungin for empiric therapy. Antimicrob Agents Chemother 62(4):e01926-17. https:\/\/doi.org\/10.1128\/AAC.01926-17","journal-title":"Antimicrob Agents Chemother"},{"key":"9776_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1201\/9780429402012-4","volume-title":"Antifungal therapy","author":"S Dharmaiah","year":"2019","unstructured":"Dharmaiah S, Sherif RA, Mukherjee PK (2019) Antifungal drug resistance: significance and mechanisms. In: Ghannoum MA, Perfect JR (eds) Antifungal therapy, 3rd edn. CRC Press, New York, NY, pp 63\u201386","edition":"3"},{"key":"9776_CR44","unstructured":"Klyasova GA, Malchikova A, Maschan M, Molchanova I, Kutsevalova O, Chernenkaya T, Vetokhina A, Zvezdkina A, Khoreva O, Kraynova L, Shushurina S (2017) In vitro activity of echinocandins and azoles against Candida spp. isolated from hematological (Hem) and non-hematological (non-Hem) patients in 11 centers of Russia. Mycoses 60:65"},{"issue":"3","key":"9776_CR45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jhin.2016.08.004","volume":"94","author":"A Chowdhary","year":"2016","unstructured":"Chowdhary A, Voss A, Meis JF (2016) Multidrug-resistant Candida auris: \u2018new kid on the block\u2019 in hospital-associated infections? J Hosp Infect 94(3):209\u2013212. https:\/\/doi.org\/10.1016\/j.jhin.2016.08.004","journal-title":"J Hosp Infect"},{"issue":"2","key":"9776_CR46","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciw691","volume":"64","author":"SR Lockhart","year":"2017","unstructured":"Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP (2017) Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64(2):134\u2013140. https:\/\/doi.org\/10.1093\/cid\/ciw691","journal-title":"Clin Infect Dis"},{"key":"9776_CR47","doi-asserted-by":"publisher","first-page":"103243","DOI":"10.1016\/j.fgb.2019.103243","volume":"131","author":"SR Lockhart","year":"2019","unstructured":"Lockhart SR (2019) Candida auris and multidrug resistance: defining the new normal. Fungal Genet Biol 131:103243. https:\/\/doi.org\/10.1016\/j.fgb.2019.103243","journal-title":"Fungal Genet Biol"},{"issue":"4","key":"9776_CR48","doi-asserted-by":"publisher","first-page":"e0175269","DOI":"10.1371\/journal.pone.0175269","volume":"12","author":"M Asadzadeh","year":"2017","unstructured":"Asadzadeh M, Ahmad S, Al-Sweih N, Khan Z (2017) Population structure and molecular genetic characterization of 5-flucytosine-susceptible and -resistant clinical Candida dubliniensis isolates from Kuwait. PloS One 12(4):e0175269. https:\/\/doi.org\/10.1371\/journal.pone.0175269","journal-title":"PloS One"},{"issue":"1","key":"9776_CR49","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1086\/524071","volume":"46","author":"ZA Kanafani","year":"2008","unstructured":"Kanafani ZA, Perfect JR (2008) Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis 46(1):120\u2013128. https:\/\/doi.org\/10.1086\/524071","journal-title":"Clin Infect Dis"},{"issue":"1","key":"9776_CR50","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1128\/AAC.02265-15","volume":"60","author":"C Charlier","year":"2015","unstructured":"Charlier C, El Sissy C, Bachelier-Bassi S, Scemla A, Quesne G, Sitterl\u00e9 E, Legendre C, Lortholary O, Bougnoux ME (2015) Acquired flucytosine resistance during combination therapy with caspofungin and flucytosine for Candida glabrata cystitis. Antimicrob Agents Chemother 60(1):662\u2013665. https:\/\/doi.org\/10.1128\/AAC.02265-15","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"9776_CR51","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1128\/aac.47.9.2717-2724.2003","volume":"47","author":"LY Young","year":"2003","unstructured":"Young LY, Hull CM, Heitman J (2003) Disruption of ergosterol biosynthesis confers resistance to amphotericin B in Candida lusitaniae. Antimicrob Agents Chemother 47(9):2717\u20132724. https:\/\/doi.org\/10.1128\/aac.47.9.2717-2724.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"9776_CR52","doi-asserted-by":"publisher","unstructured":"Veselov AV, Vasilyeva NV, Bogomolova TS, Raush ER, Kutsevalova OYu, Nizhegorodceva IA, Petrova LV, Shmidt NV, Moskvitina EN, Sukhorukova MV, Ivanchik NV, Kozlov RS (2018) Susceptibility testing of Candida glabrata clinical strains to echinocandins using Sensititre\u2122 YeastOne\u2122 system. Clin Microbiol Antimicrob Chemother 20(1):49-54. https:\/\/doi.org\/10.36488\/cmac.2018.1.49-54","DOI":"10.36488\/cmac.2018.1.49-54"},{"key":"9776_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-50409-4","volume-title":"Candida albicans: cellular and molecular biology","author":"R Prasad","year":"2017","unstructured":"Prasad R (2017) Candida albicans: cellular and molecular biology, 2nd edn. Springer International Publishing, New York","edition":"2"},{"issue":"4","key":"9776_CR54","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jgar.2014.09.002","volume":"2","author":"G Morace","year":"2014","unstructured":"Morace G, Perdoni F, Borghi E (2014) Antifungal drug resistance in Candida species. J Glob Antimicrob Resist 2(4):254\u2013259. https:\/\/doi.org\/10.1016\/j.jgar.2014.09.002","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"9776_CR55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jac\/46.2.171","volume":"46","author":"A Vermes","year":"2000","unstructured":"Vermes A, Guchelaar HJ, Dankert J (2000) Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 46(2):171\u2013179. https:\/\/doi.org\/10.1093\/jac\/46.2.171","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"9776_CR56","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1128\/AAC.03470-14","volume":"59","author":"SA Flowers","year":"2015","unstructured":"Flowers SA, Col\u00f3n B, Whaley SG, Schuler MA, Rogers PD (2015) Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans. Antimicrob Agents Chemother 59(1):450\u2013460. https:\/\/doi.org\/10.1128\/AAC.03470-14","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"9776_CR57","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/1567-1364.12042","volume":"13","author":"MJ Xiang","year":"2013","unstructured":"Xiang MJ, Liu JY, Ni PH, Wang S, Shi C, Wei B, Ni YX, Ge HL (2013) Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans. FEMS Yeast Res 13(4):386\u2013393. https:\/\/doi.org\/10.1111\/1567-1364.12042","journal-title":"FEMS Yeast Res"},{"issue":"4","key":"9776_CR58","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/myc.12469","volume":"59","author":"SS Gon\u00e7alves","year":"2016","unstructured":"Gon\u00e7alves SS, Souza A, Chowdhary A, Meis JF, Colombo AL (2016) Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus. Mycoses 59(4):198\u2013219. https:\/\/doi.org\/10.1111\/myc.12469","journal-title":"Mycoses"},{"issue":"5","key":"9776_CR59","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1128\/AAC.49.5.1745-1752.2005","volume":"49","author":"S MacPherson","year":"2005","unstructured":"MacPherson S, Akache B, Weber S, De Deken X, Raymond M, Turcotte B (2005) Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes. Antimicrob Agents Chemother 49(5):1745\u20131752. https:\/\/doi.org\/10.1128\/AAC.49.5.1745-1752.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"9776_CR60","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1128\/AAC.00995-10","volume":"55","author":"SJ Hoot","year":"2011","unstructured":"Hoot SJ, Smith AR, Brown RP, White TC (2011) An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans. Antimicrob Agents Chemother 55(2):940\u2013942. https:\/\/doi.org\/10.1128\/AAC.00995-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"9776_CR61","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1128\/JB.181.3.700-708.1999","volume":"181","author":"AM Alarco","year":"1999","unstructured":"Alarco AM, Raymond M (1999) The bZip transcription factor Cap1p is involved in multidrug resistance and oxidative stress response in Candida albicans. J Bacteriol 181(3):700\u2013708. https:\/\/doi.org\/10.1128\/JB.181.3.700-708.1999","journal-title":"J Bacteriol"},{"issue":"11","key":"9776_CR62","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1371\/journal.ppat.0030164","volume":"3","author":"J Morschh\u00e4user","year":"2007","unstructured":"Morschh\u00e4user J, Barker KS, Liu TT, BlaB-Warmuth J, Homayouni R, Rogers PD (2007) The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans. PLoS Pathog 3(11):e164. https:\/\/doi.org\/10.1371\/journal.ppat.0030164","journal-title":"PLoS Pathog"},{"key":"9776_CR63","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3389\/fmicb.2016.02173","volume":"7","author":"SG Whaley","year":"2017","unstructured":"Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, Rogers PD (2017) Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol 7:2173. https:\/\/doi.org\/10.3389\/fmicb.2016.02173","journal-title":"Front Microbiol"},{"issue":"11","key":"9776_CR64","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1128\/AAC.00348-10","volume":"54","author":"CM Martel","year":"2010","unstructured":"Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Rolley N, Kelly DE, Kelly SL (2010) Identification and characterization of four azole-resistant erg3 mutants of Candida albicans. Antimicrob Agents Chemother 54(11):4527\u20134533. https:\/\/doi.org\/10.1128\/AAC.00348-10","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"9776_CR65","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/jac\/dks186","volume":"67","author":"F Morio","year":"2012","unstructured":"Morio F, Pagniez F, Lacroix C, Miegeville M, Le Pape P (2012) Amino acid substitutions in the Candida albicans sterol \u03945,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence. J Antimicrob Chemother 67(9):2131\u20132138. https:\/\/doi.org\/10.1093\/jac\/dks186","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"9776_CR66","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1128\/EC.3.6.1639-1652.2004","volume":"3","author":"AT Coste","year":"2004","unstructured":"Coste AT, Karababa M, Ischer F, Bille J, Sanglard D (2004) TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell 3(6):1639\u20131652. https:\/\/doi.org\/10.1128\/EC.3.6.1639-1652.2004","journal-title":"Eukaryot Cell"},{"issue":"9","key":"9776_CR67","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1128\/aac.44.9.2411-2418.2000","volume":"44","author":"H Nakayama","year":"2000","unstructured":"Nakayama H, Izuta M, Nakayama N, Arisawa M, Aoki Y (2000) Depletion of the squalene synthase (ERG9) gene does not impair growth of Candida glabrata in mice. Antimicrob Agents Chemother 44(9):2411\u20132418. https:\/\/doi.org\/10.1128\/aac.44.9.2411-2418.2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"9776_CR68","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1093\/jac\/dkm321","volume":"60","author":"H Nakayama","year":"2007","unstructured":"Nakayama H, Tanabe K, Bard M, Hodgson W, Wu S, Takemori D, Aoyama T, Kumaraswami NS, Metzler L, Takano Y, Chibana H, Niimi M (2007) The Candida glabrata putative sterol transporter gene CgAUS1 protects cells against azoles in the presence of serum. J Antimicrob Chemother 60(6):1264\u20131272. https:\/\/doi.org\/10.1093\/jac\/dkm321","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"9776_CR69","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1080\/13693780600561544","volume":"44","author":"J Guinea","year":"2006","unstructured":"Guinea J, S\u00e1nchez-Somolinos M, Cuevas O, Pel\u00e1ez T, Bouza E (2006) Fluconazole resistance mechanisms in Candida krusei: the contribution of efflux-pumps. Med Mycol 44(6):575\u2013578. https:\/\/doi.org\/10.1080\/13693780600561544","journal-title":"Med Mycol"},{"issue":"2","key":"9776_CR70","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1128\/AAC.01095-08","volume":"53","author":"E Lamping","year":"2009","unstructured":"Lamping E, Ranchod A, Nakamura K, Tyndall JD, Niimi K, Holmes AR, Niimi M, Cannon RD (2009) Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei. Antimicrob Agents Chemother 53(2):354\u2013369. https:\/\/doi.org\/10.1128\/AAC.01095-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"Pt 10","key":"9776_CR71","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1099\/00221287-145-10-2701","volume":"145","author":"P Marichal","year":"1999","unstructured":"Marichal P, Koymans L, Willemsens S, Bellens D, Verhasselt P, Luyten W, Borgers M, Ramaekers F, Odds FC, Vanden Bossche H (1999) Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology (Reading) 145(Pt 10):2701\u20132713. https:\/\/doi.org\/10.1099\/00221287-145-10-2701","journal-title":"Microbiology (Reading)"},{"issue":"5","key":"9776_CR72","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1348-0421.2002.tb02702.x","volume":"46","author":"K Maebashi","year":"2002","unstructured":"Maebashi K, Kudoh M, Nishiyama Y, Makimura K, Uchida K, Mori T, Yamaguchi H (2002) A novel mechanism of fluconazole resistance associated with fluconazole sequestration in Candida albicans isolates from a myelofibrosis patient. Microbiol Immunol 46(5):317\u2013326. https:\/\/doi.org\/10.1111\/j.1348-0421.2002.tb02702.x","journal-title":"Microbiol Immunol"},{"issue":"12","key":"9776_CR73","doi-asserted-by":"publisher","first-page":"6417","DOI":"10.1128\/AAC.01145-12","volume":"56","author":"CM Hull","year":"2012","unstructured":"Hull CM, Bader O, Parker JE, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL (2012) Two clinical isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B both harbor mutations in ERG2. Antimicrob Agents Chemother 56(12):6417\u20136421. https:\/\/doi.org\/10.1128\/AAC.01145-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"9776_CR74","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1574-6968.1994.tb07140.x","volume":"122","author":"SL Kelly","year":"1994","unstructured":"Kelly SL, Lamb DC, Taylor M, Corran AJ, Baldwin BC, Powderly WG (1994) Resistance to amphotericin B associated with defective sterol delta 8\u2013>7 isomerase in a Cryptococcus neoformans strain from an AIDS patient. FEMS Microbiol Lett 122(1\u20132):39\u201342. https:\/\/doi.org\/10.1111\/j.1574-6968.1994.tb07140.x","journal-title":"FEMS Microbiol Lett"},{"issue":"1","key":"9776_CR75","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1128\/AAC.41.1.196","volume":"41","author":"FS Nolte","year":"1997","unstructured":"Nolte FS, Parkinson T, Falconer DJ, Dix S, Williams J, Gilmore C, Geller R, Wingard JR (1997) Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. Antimicrob Agents Chemother 41(1):196\u2013199. https:\/\/doi.org\/10.1128\/AAC.41.1.196","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"9776_CR76","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1128\/AAC.01510-06","volume":"51","author":"P Vandeputte","year":"2007","unstructured":"Vandeputte P, Tronchin G, Berg\u00e8s T, Hennequin C, Chabasse D, Bouchara JP (2007) Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth. Antimicrob Agents Chemother 51(3):982\u2013990. https:\/\/doi.org\/10.1128\/AAC.01510-06","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"9776_CR77","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1128\/AAC.01315-08","volume":"53","author":"JB Anderson","year":"2009","unstructured":"Anderson JB, Sirjusingh C, Syed N, Lafayette S (2009) Gene expression and evolution of antifungal drug resistance. Antimicrob Agents Chemother 53(5):1931\u20131936. https:\/\/doi.org\/10.1128\/AAC.01315-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"9776_CR78","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/jac\/dkh336","volume":"54","author":"KS Barker","year":"2004","unstructured":"Barker KS, Crisp S, Wiederhold N, Lewis RE, Bareither B, Eckstein J, Barbuch R, Bard M, Rogers PD (2004) Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J Antimicrob Chemother 54(2):376\u2013385. https:\/\/doi.org\/10.1093\/jac\/dkh336","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"9776_CR79","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/infdis\/129.1.53","volume":"129","author":"RA Woods","year":"1974","unstructured":"Woods RA, Bard M, Jackson IE, Drutz DJ (1974) Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria. J Infect Dis 129(1):53\u201358. https:\/\/doi.org\/10.1093\/infdis\/129.1.53","journal-title":"J Infect Dis"},{"issue":"5","key":"9776_CR80","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1021\/acsinfecdis.0c00117","volume":"6","author":"LN Silva","year":"2020","unstructured":"Silva LN, Oliveira S, Magalh\u00e3es LB, Andrade Neto VV, Torres-Santos EC, Carvalho M, Pereira MD, Branquinha MH, Santos A (2020) Unmasking the amphotericin b resistance mechanisms in Candida haemulonii species complex. ACS Infect Dis 6(5):1273\u20131282. https:\/\/doi.org\/10.1021\/acsinfecdis.0c00117","journal-title":"ACS Infect Dis"},{"issue":"3","key":"9776_CR81","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0923-2508(03)00049-4","volume":"154","author":"K Bahmed","year":"2003","unstructured":"Bahmed K, Bonaly R, Coulon J (2003) Relation between cell wall chitin content and susceptibility to amphotericin B in Kluyveromyces. Candida and Schizosaccharomyces species. Res Microbiol 154(3):215\u2013222. https:\/\/doi.org\/10.1016\/S0923-2508(03)00049-4","journal-title":"Candida and Schizosaccharomyces species. Res Microbiol"},{"issue":"1","key":"9776_CR82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-2672.1976.tb00605.x","volume":"41","author":"SM Hammond","year":"1976","unstructured":"Hammond SM, Kliger BN (1976) Differential effects of monovalent and divalent ions upon the mode of action of the polyene antibiotic candicidin. J Appl Bacteriol 41(1):59\u201368. https:\/\/doi.org\/10.1111\/j.1365-2672.1976.tb00605.x","journal-title":"J Appl Bacteriol"},{"issue":"6","key":"9776_CR83","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/QCO.0000000000000111","volume":"27","author":"MC Arendrup","year":"2014","unstructured":"Arendrup MC, Perlin DS (2014) Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis 27(6):484\u2013492. https:\/\/doi.org\/10.1097\/QCO.0000000000000111","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"9776_CR84","doi-asserted-by":"publisher","first-page":"S445","DOI":"10.1093\/infdis\/jix131","volume":"216","author":"MC Arendrup","year":"2017","unstructured":"Arendrup MC, Patterson TF (2017) Multidrug-resistant Candida: epidemiology, molecular mechanisms, and treatment. J Infect Dis 216(3):S445\u2013S451. https:\/\/doi.org\/10.1093\/infdis\/jix131","journal-title":"J Infect Dis"},{"issue":"6","key":"9776_CR85","doi-asserted-by":"publisher","first-page":"S612","DOI":"10.1093\/cid\/civ791","volume":"61","author":"DS Perlin","year":"2015","unstructured":"Perlin DS (2015) Echinocandin resistance in Candida. Clin Infect Dis 61(6):S612\u2013S617. https:\/\/doi.org\/10.1093\/cid\/civ791","journal-title":"Clin Infect Dis"},{"issue":"6","key":"9776_CR86","doi-asserted-by":"publisher","first-page":"e00238","DOI":"10.1128\/AAC.00238-18","volume":"62","author":"M Kordalewska","year":"2018","unstructured":"Kordalewska M, Lee A, Park S, Berrio I, Chowdhary A, Zhao Y, Perlin DS (2018) Understanding echinocandin resistance in the emerging pathogen Candida auris. Antimicrob Agents Chemother 62(6):e00238-18. https:\/\/doi.org\/10.1128\/AAC.00238-18","journal-title":"Antimicrob Agents Chemother"},{"key":"9776_CR87","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fmed.2018.00028","volume":"5","author":"M Cavalheiro","year":"2018","unstructured":"Cavalheiro M, Teixeira MC (2018) Candida biofilms: threats, challenges, and promising strategies. Front Med (Lausanne) 5:28. https:\/\/doi.org\/10.3389\/fmed.2018.00028","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"9776_CR88","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1128\/jcm.39.9.3234-3240.2001","volume":"39","author":"G Ramage","year":"2001","unstructured":"Ramage G, Vande Walle K, Wickes BL, L\u00f3pez-Ribot JL (2001) Biofilm formation by Candida dubliniensis. J Clin Microbiol 39(9):3234\u20133240. https:\/\/doi.org\/10.1128\/jcm.39.9.3234-3240.2001","journal-title":"J Clin Microbiol"},{"issue":"6","key":"9776_CR89","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/jac\/dkf049","volume":"49","author":"G Ramage","year":"2002","unstructured":"Ramage G, Bachmann S, Patterson TF, Wickes BL, L\u00f3pez-Ribot JL (2002) Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 49(6):973\u2013980. https:\/\/doi.org\/10.1093\/jac\/dkf049","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"9776_CR90","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1128\/iai.71.8.4333-4340.2003","volume":"71","author":"PK Mukherjee","year":"2003","unstructured":"Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA (2003) Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 71(8):4333\u20134340. https:\/\/doi.org\/10.1128\/iai.71.8.4333-4340.2003","journal-title":"Infect Immun"},{"issue":"1","key":"9776_CR91","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/jof3010008","volume":"3","author":"S Silva","year":"2017","unstructured":"Silva S, Rodrigues CF, Ara\u00fajo D, Rodrigues ME, Henriques M (2017) Candida species biofilms\u2019 antifungal resistance. J Fungi (Basel) 3(1):8. https:\/\/doi.org\/10.3390\/jof3010008","journal-title":"J Fungi (Basel)"},{"issue":"2","key":"9776_CR92","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1128\/cmr.17.2.255-267.2004","volume":"17","author":"EM Kojic","year":"2004","unstructured":"Kojic EM, Darouiche RO (2004) Candida infections of medical devices. Clin Microbiol Rev 17(2):255\u2013267. https:\/\/doi.org\/10.1128\/cmr.17.2.255-267.2004","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"9776_CR93","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/08927014.2014.996143","volume":"31","author":"YW Cavalcanti","year":"2015","unstructured":"Cavalcanti YW, Morse DJ, da Silva WJ, Del-Bel-Cury AA, Wei X, Wilson M, Milward P, Lewis M, Bradshaw D, Williams DW (2015) Virulence and pathogenicity of Candida albicans is enhanced in biofilms containing oral bacteria. Biofouling 31(1):27\u201338. https:\/\/doi.org\/10.1080\/08927014.2014.996143","journal-title":"Biofouling"},{"issue":"8","key":"9776_CR94","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.archoralbio.2008.02.015","volume":"53","author":"T Pereira-Cenci","year":"2008","unstructured":"Pereira-Cenci T, Deng DM, Kraneveld EA, Manders EM, Del Bel Cury AA, Ten Cate JM, Crielaard W (2008) The effect of Streptococcus mutans and Candida glabrata on Candida albicans biofilms formed on different surfaces. Arch Oral Biol 53(8):755\u2013764. https:\/\/doi.org\/10.1016\/j.archoralbio.2008.02.015","journal-title":"Arch Oral Biol"},{"issue":"1","key":"9776_CR95","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1590\/s1678-77572012000100013","volume":"20","author":"AK Pathak","year":"2012","unstructured":"Pathak AK, Sharma S, Shrivastva P (2012) Multi-species biofilm of Candida albicans and non-Candida albicans Candida species on acrylic substrate. J Appl Oral Sci 20(1):70\u201375. https:\/\/doi.org\/10.1590\/s1678-77572012000100013","journal-title":"J Appl Oral Sci"},{"key":"9776_CR96","doi-asserted-by":"publisher","unstructured":"Rodrigues ME, Gomes F, Rodrigues CF (2019) Candida spp.\/bacteria mixed biofilms. J Fungi (Basel) 6(1):5. https:\/\/doi.org\/10.3390\/jof6010005","DOI":"10.3390\/jof6010005"},{"issue":"1","key":"9776_CR97","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/jof6010021","volume":"6","author":"JE Nett","year":"2020","unstructured":"Nett JE, Andes DR (2020) Contributions of the biofilm matrix to Candida pathogenesis. J Fungi (Basel) 6(1):21. https:\/\/doi.org\/10.3390\/jof6010021","journal-title":"J Fungi (Basel)"},{"issue":"8","key":"9776_CR98","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1128\/AAC.42.8.2146","volume":"42","author":"GS Baillie","year":"1998","unstructured":"Baillie GS, Douglas LJ (1998) Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B. Antimicrob Agents Chemother 42(8):2146\u20132149. https:\/\/doi.org\/10.1128\/AAC.42.8.2146","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"9776_CR99","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrmicro1557","volume":"5","author":"K Lewis","year":"2007","unstructured":"Lewis K (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol 5(1):48\u201356. https:\/\/doi.org\/10.1038\/nrmicro1557","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"9776_CR100","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/jac\/dkv445","volume":"71","author":"A Ko\u0142aczkowska","year":"2016","unstructured":"Ko\u0142aczkowska A, Ko\u0142aczkowski M (2016) Drug resistance mechanisms and their regulation in non-albicans Candida species. J Antimicrob Chemother 71(6):1438\u20131450. https:\/\/doi.org\/10.1093\/jac\/dkv445","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"9776_CR101","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1128\/aac.39.9.2128","volume":"39","author":"SP Hawser","year":"1995","unstructured":"Hawser SP, Douglas LJ (1995) Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 39(9):2128\u20132131. https:\/\/doi.org\/10.1128\/aac.39.9.2128","journal-title":"Antimicrob Agents Chemother"},{"key":"9776_CR102","doi-asserted-by":"publisher","unstructured":"Melo AS, Bizerra FC, Freym\u00fcller E, Arthington-Skaggs BA, Colombo AL (2011) Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med Mycol 49(3):253\u2013262. https:\/\/doi.org\/10.3109\/13693786.2010.530032","DOI":"10.3109\/13693786.2010.530032"},{"issue":"6","key":"9776_CR103","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1128\/AAC.02541-12","volume":"57","author":"M Simitsopoulou","year":"2013","unstructured":"Simitsopoulou M, Peshkova P, Tasina E, Katragkou A, Kyrpitzi D, Velegraki A, Walsh TJ, Roilides E (2013) Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates. Antimicrob Agents Chemother 57(6):2562\u20132570. https:\/\/doi.org\/10.1128\/AAC.02541-12","journal-title":"Antimicrob Agents Chemother"},{"key":"9776_CR104","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2011.02036.x","author":"H Bernhardt","year":"2011","unstructured":"Bernhardt H, Knoke M, Bernhardt J (2011) Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation. Mycoses. https:\/\/doi.org\/10.1111\/j.1439-0507.2011.02036.x","journal-title":"Mycoses"},{"issue":"2","key":"9776_CR105","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3201\/eid2302.161320","volume":"23","author":"L Sherry","year":"2017","unstructured":"Sherry L, Ramage G, Kean R, Borman A, Johnson EM, Richardson MD, Rautemaa-Richardson R (2017) Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris. Emerg Infect Dis 23(2):328\u2013331. https:\/\/doi.org\/10.3201\/eid2302.161320","journal-title":"Emerg Infect Dis"},{"key":"9776_CR106","doi-asserted-by":"publisher","unstructured":"Dominguez EG, Zarnowski R, Choy HL, Zhao M, Sanchez H, Nett JE, Andes DR (2019). Conserved role for biofilm matrix polysaccharides in Candida auris drug resistance. mSphere, 4(1):e00680-18. https:\/\/doi.org\/10.1128\/mSphereDirect.00680-18","DOI":"10.1128\/mSphereDirect.00680-18"},{"key":"9776_CR107","doi-asserted-by":"publisher","unstructured":"Kean R, Delaney C, Sherry L, Borman A, Johnson EM, Richardson MD, Rautemaa-Richardson R, Williams C, Ramage G (2018) Transcriptome assembly and profiling of Candida auris reveals novel insights into biofilm-mediated resistance. mSphere 3(4):e00334-18. https:\/\/doi.org\/10.1128\/mSphere.00334-18","DOI":"10.1128\/mSphere.00334-18"},{"issue":"9","key":"9776_CR108","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1128\/aac.45.9.2475-2479.2001","volume":"45","author":"G Ramage","year":"2001","unstructured":"Ramage G, Vande Walle K, Wickes BL, L\u00f3pez-Ribot JL (2001) Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45(9):2475\u20132479. https:\/\/doi.org\/10.1128\/aac.45.9.2475-2479.2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"8\u20139","key":"9776_CR109","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.micinf.2009.04.018","volume":"11","author":"F Hasan","year":"2009","unstructured":"Hasan F, Xess I, Wang X, Jain N, Fries BC (2009) Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect 11(8\u20139):753\u2013761. https:\/\/doi.org\/10.1016\/j.micinf.2009.04.018","journal-title":"Microbes Infect"},{"issue":"3","key":"9776_CR110","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/jof6030099","volume":"6","author":"R Kov\u00e1cs","year":"2020","unstructured":"Kov\u00e1cs R, Majoros L (2020) Fungal quorum-sensing molecules: a review of their antifungal effect against Candida biofilms. J Fungi (Basel) 6(3):99. https:\/\/doi.org\/10.3390\/jof6030099","journal-title":"J Fungi (Basel)"},{"issue":"14","key":"9776_CR111","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1073\/pnas.0401416101","volume":"101","author":"H Chen","year":"2004","unstructured":"Chen H, Fujita M, Feng Q, Clardy J, Fink GR (2004) Tyrosol is a quorum-sensing molecule in Candida albicans. Proc Natl Acad Sci U S A 101(14):5048\u20135052. https:\/\/doi.org\/10.1073\/pnas.0401416101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"9776_CR112","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1128\/AEM.02765-05","volume":"72","author":"KW Nickerson","year":"2006","unstructured":"Nickerson KW, Atkin AL, Hornby JM (2006) Quorum sensing in dimorphic fungi: farnesol and beyond. Appl Environ Microbiol 72(6):3805\u20133813. https:\/\/doi.org\/10.1128\/AEM.02765-05","journal-title":"Appl Environ Microbiol"},{"issue":"10","key":"9776_CR113","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.3390\/molecules24101950","volume":"24","author":"A Mehmood","year":"2019","unstructured":"Mehmood A, Liu G, Wang X, Meng G, Wang C, Liu Y (2019) Fungal quorum-sensing molecules and inhibitors with potential antifungal activity: a review. Molecules 24(10):1950. https:\/\/doi.org\/10.3390\/molecules24101950","journal-title":"Molecules"},{"issue":"2","key":"9776_CR114","doi-asserted-by":"publisher","first-page":"e02225","DOI":"10.1128\/AAC.02225-19","volume":"64","author":"D Ghosh","year":"2020","unstructured":"Ghosh D, Veeraraghavan B, Elangovan R, Vivekanandan P (2020) Antibiotic resistance and epigenetics: more to it than meets the eye. Antimicrob Agents Chemother 64(2):e02225-19. https:\/\/doi.org\/10.1128\/AAC.02225-19","journal-title":"Antimicrob Agents Chemother"},{"key":"9776_CR115","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3389\/fmicb.2016.01238","volume":"7","author":"C Garnaud","year":"2016","unstructured":"Garnaud C, Champleboux M, Maubon D, Cornet M, Govin J (2016) Histone deacetylases and their inhibition in Candida species. Front Microbiol 7:1238. https:\/\/doi.org\/10.3389\/fmicb.2016.01238","journal-title":"Front Microbiol"},{"key":"9776_CR116","doi-asserted-by":"publisher","first-page":"103253","DOI":"10.1016\/j.fgb.2019.103253","volume":"132","author":"Z Chang","year":"2019","unstructured":"Chang Z, Yadav V, Lee SC, Heitman J (2019) Epigenetic mechanisms of drug resistance in fungi. Fungal Genet Biol 132:103253. https:\/\/doi.org\/10.1016\/j.fgb.2019.103253","journal-title":"Fungal Genet Biol"},{"issue":"4","key":"9776_CR117","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.febslet.2015.01.011","volume":"589","author":"JE Lee","year":"2015","unstructured":"Lee JE, Oh JH, Ku M, Kim J, Lee JS, Kang SO (2015) Ssn6 has dual roles in Candida albicans filament development through the interaction with Rpd31. FEBS Lett 589(4):513\u2013520. https:\/\/doi.org\/10.1016\/j.febslet.2015.01.011","journal-title":"FEBS Lett."},{"issue":"7","key":"9776_CR118","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nm.2175","volume":"16","author":"H Wurtele","year":"2010","unstructured":"Wurtele H, Tsao S, L\u00e9pine G, Mullick A, Tremblay J, Drogaris P, Lee EH, Thibault P, Verreault A, Raymond M (2010) Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat Med 16(7):774\u2013780. https:\/\/doi.org\/10.1038\/nm.2175","journal-title":"Nat Med"},{"key":"9776_CR119","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fgene.2020.00351","volume":"11","author":"AD Chybowska","year":"2020","unstructured":"Chybowska AD, Childers DS, Farrer RA (2020) Nine things genomics can tell us about Candida auris. Front Genet 11:351. https:\/\/doi.org\/10.3389\/fgene.2020.00351","journal-title":"Front Genet"},{"issue":"1","key":"9776_CR120","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.fbr.2017.07.002","volume":"32","author":"LS Rai","year":"2018","unstructured":"Rai LS, Singha R, Brahma P, Sanyal K (2018) Epigenetic determinants of phenotypic plasticity in Candida albicans. Fungal Biol Rev 32(1):10\u201319. https:\/\/doi.org\/10.1016\/j.fbr.2017.07.002","journal-title":"Fungal Biol Rev"},{"issue":"3","key":"9776_CR121","first-page":"151","volume":"9","author":"K Tanaka","year":"1959","unstructured":"Tanaka K, Iwai I, Okajima Y, Konotsune T (1959) Antifungal activity of some synthetic acetylenic compounds. Antibiot Chemother (Northfield). 9(3):151\u2013155","journal-title":"Antibiot Chemother (Northfield)."},{"key":"9776_CR122","unstructured":"Rotmistrov MN, Kulik GV, Vasilevskaya IA (1967) Synthetic antimicrobial substances for the medical treatment of skin and internal diseases of microbial origin. Acta Univ Debrecen Ser Phys Chim 145\u2013155"},{"key":"9776_CR123","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2217\/fmb.15.118","volume":"11","author":"M Girardot","year":"2016","unstructured":"Girardot M, Imbert C (2016) Novel strategies against Candida biofilms: interest of synthetic compounds. Future Microbiol 11:69\u201379. https:\/\/doi.org\/10.2217\/fmb.15.118","journal-title":"Future Microbiol"},{"issue":"1","key":"9776_CR124","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2191-2858-1-15","volume":"1","author":"DK Aneja","year":"2011","unstructured":"Aneja DK, Lohan P, Arora S, Sharma C, Aneja KR, Prakash O (2011) Synthesis of new pyrazolyl-2, 4-thiazolidinediones as antibacterial and antifungal agents. Org Med Chem Lett 1(1):15. https:\/\/doi.org\/10.1186\/2191-2858-1-15","journal-title":"Org Med Chem Lett"},{"issue":"6","key":"9776_CR125","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1021\/co400022r","volume":"15","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Wang S, Wu S, Zhu S, Dong G, Miao Z, Yao J, Zhang W, Sheng C, Wang W (2013) Facile construction of structurally diverse thiazolidinedione-derived compounds via divergent stereoselective cascade organocatalysis and their biological exploratory studies. ACS Comb Sci 15(6):298\u2013308. https:\/\/doi.org\/10.1021\/co400022r","journal-title":"ACS Comb Sci"},{"issue":"1","key":"9776_CR126","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40199-014-0086-1","volume":"23","author":"RS Bahare","year":"2015","unstructured":"Bahare RS, Ganguly S, Choowongkomon K, Seetaha S (2015) Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones. Daru 23(1):6. https:\/\/doi.org\/10.1186\/s40199-014-0086-1","journal-title":"Daru"},{"issue":"1","key":"9776_CR127","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13065-017-0357-2","volume":"11","author":"S Sucheta Tahlan","year":"2017","unstructured":"Sucheta Tahlan S, Verma PK (2017) Biological potential of thiazolidinedione derivatives of synthetic origin. Chem Cent J 11(1):130. https:\/\/doi.org\/10.1186\/s13065-017-0357-2","journal-title":"Chem Cent J"},{"issue":"5","key":"9776_CR128","doi-asserted-by":"publisher","first-page":"e93225","DOI":"10.1371\/journal.pone.0093225","volume":"9","author":"M Feldman","year":"2014","unstructured":"Feldman M, Al-Quntar A, Polacheck I, Friedman M, Steinberg D (2014) Therapeutic potential of thiazolidinedione-8 as an antibiofilm agent against Candida albicans. PloS One 9(5):e93225. https:\/\/doi.org\/10.1371\/journal.pone.0093225","journal-title":"PloS One"},{"key":"9776_CR129","doi-asserted-by":"publisher","unstructured":"Feldman M, Ginsburg I, Al-Quntar A, Steinberg D (2016) Thiazolidinedione-8 alters symbiotic relationship in C. albicans-S. mutans dual species biofilm. Front Microbiol 7:140. https:\/\/doi.org\/10.3389\/fmicb.2016.00140","DOI":"10.3389\/fmicb.2016.00140"},{"key":"9776_CR130","doi-asserted-by":"publisher","first-page":"3510124","DOI":"10.1155\/2017\/3510124","volume":"2017","author":"M Feldman","year":"2017","unstructured":"Feldman M, Shenderovich J, Lavy E, Friedman M, Steinberg D (2017) A sustained-release membrane of thiazolidinedione-8: effect on formation of a Candida\/bacteria mixed biofilm on hydroxyapatite in a continuous flow model. Biomed Res Int\u00a02017:3510124. https:\/\/doi.org\/10.1155\/2017\/3510124","journal-title":"Biomed Res Int."},{"issue":"12","key":"9776_CR131","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1002\/cmdc.201402320","volume":"9","author":"S Wu","year":"2014","unstructured":"Wu S, Zhang Y, He X, Che X, Wang S, Liu Y, Jiang Y, Liu N, Dong G, Yao J, Miao Z, Wang Y, Zhang W, Sheng C (2014) From antidiabetic to antifungal: discovery of highly potent triazole-thiazolidinedione hybrids as novel antifungal agents. Chem Med Chem 9(12):2639\u20132646. https:\/\/doi.org\/10.1002\/cmdc.201402320","journal-title":"ChemMedChem"},{"key":"9776_CR132","first-page":"124","volume":"9","author":"F Sahin","year":"1984","unstructured":"Sahin F, Safak C, Yegen O (1984) Bilgin AA (1984) Synthesis of some chalcone derivatives and their antifungal effects against Candida albicans. FABAD J 9:124\u2013132","journal-title":"FABAD J"},{"key":"9776_CR133","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1472-765X.1994.tb00800.x","volume":"18","author":"M Sato","year":"1994","unstructured":"Sato M, Tsuchiya H, Akagiri M, Fujiwara S, Fujii T, Takagi N, Matsuura N, Iinuma M (1994) Growth inhibitory properties of chalcones to Candida. Lett Appl Microbiol 18:53\u201355. https:\/\/doi.org\/10.1111\/j.1472-765X.1994.tb00800.x","journal-title":"Lett Appl Microbiol"},{"issue":"1","key":"9776_CR134","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ejmech.2006.08.012","volume":"42","author":"D Batovska","year":"2007","unstructured":"Batovska D, Parushev S, Slavova A, Bankova V, Tsvetkova I, Ninova M, Najdenski H (2007) Study on the substituents\u2019 effects of a series of synthetic chalcones against the yeast Candida albicans. Eur J Med Chem 42(1):87\u201392. https:\/\/doi.org\/10.1016\/j.ejmech.2006.08.012","journal-title":"Eur J Med Chem"},{"issue":"19","key":"9776_CR135","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1016\/j.bmcl.2007.08.021","volume":"17","author":"V Tomar","year":"2007","unstructured":"Tomar V, Bhattacharjee G, Kamaluddin Kumar A (2007) Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety. Bioorg Med Chem Lett 17(19):5321\u20135324. https:\/\/doi.org\/10.1016\/j.bmcl.2007.08.021","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"9776_CR136","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/cbdv.200900027","volume":"7","author":"I Karaman","year":"2010","unstructured":"Karaman I, Gezegen H, G\u00fcrdere MB, Dingil A, Ceylan M (2010) Screening of biological activities of a series of chalcone derivatives against human pathogenic microorganisms. Chem Biodivers 7(2):400\u2013408. https:\/\/doi.org\/10.1002\/cbdv.200900027","journal-title":"Chem Biodivers"},{"issue":"8","key":"9776_CR137","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41429-018-0048-9","volume":"71","author":"JT Andrade","year":"2018","unstructured":"Andrade JT, Santos F, Lima WG, Sousa C, Oliveira L, Ribeiro R, Gomes A, Ara\u00fajo M, Villar J, Ferreira J (2018) Design, synthesis, biological activity and structure-activity relationship studies of chalcone derivatives as potential anti-Candida agents. J Antibiot (Tokyo) 71(8):702\u2013712. https:\/\/doi.org\/10.1038\/s41429-018-0048-9","journal-title":"J Antibiot (Tokyo)"},{"key":"9776_CR138","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejmech.2016.02.041","volume":"113","author":"R Kant","year":"2016","unstructured":"Kant R, Kumar D, Agarwal D, Gupta RD, Tilak R, Awasthi SK, Agarwal A (2016) Synthesis of newer 1,2,3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities. Eur J Med Chem 113:34\u201349. https:\/\/doi.org\/10.1016\/j.ejmech.2016.02.041","journal-title":"Eur J Med Chem"},{"issue":"12","key":"9776_CR139","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1039\/c7md00440k","volume":"8","author":"A Ahmad","year":"2017","unstructured":"Ahmad A, Wani MY, Patel M, Sobral A, Duse AG, Aqlan FM, Al-Bogami AS (2017) Synergistic antifungal effect of cyclized chalcone derivatives and fluconazole against Candida albicans. Med Chem Comm 8(12):2195\u20132207. https:\/\/doi.org\/10.1039\/c7md00440k","journal-title":"MedChemComm"},{"issue":"13","key":"9776_CR140","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1016\/j.bmcl.2016.05.013","volume":"26","author":"YH Wang","year":"2016","unstructured":"Wang YH, Dong HH, Zhao F, Wang J, Yan F, Jiang YY, Jin YS (2016) The synthesis and synergistic antifungal effects of chalcones against drug resistant Candida albicans. Bioorg Med Chem Lett 26(13):3098\u20133102. https:\/\/doi.org\/10.1016\/j.bmcl.2016.05.013","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"9776_CR141","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ejmech.2005.01.013","volume":"41","author":"A Cukurovali","year":"2006","unstructured":"Cukurovali A, Yilmaz I, Gur S, Kazaz C (2006) Synthesis, antibacterial and antifungal activity of some new thiazolylhydrazone derivatives containing 3-substituted cyclobutane ring. Eur J Med Chem 41(2):201\u2013207. https:\/\/doi.org\/10.1016\/j.ejmech.2005.01.013","journal-title":"Eur J Med Chem"},{"issue":"16","key":"9776_CR142","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1016\/j.bmcl.2007.05.078","volume":"17","author":"F Chimenti","year":"2007","unstructured":"Chimenti F, Bizzarri B, Maccioni E, Secci D, Bolasco A, Fioravanti R, Chimenti P, Granese A, Carradori S, Rivanera D, Lilli D, Zicari A, Distinto S (2007) Synthesis and in vitro activity of 2-thiazolylhydrazone derivatives compared with the activity of clotrimazole against clinical isolates of Candida spp. Bioorg Med Chem Lett 17(16):4635\u20134640. https:\/\/doi.org\/10.1016\/j.bmcl.2007.05.078","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"9776_CR143","doi-asserted-by":"publisher","first-page":"14809","DOI":"10.3390\/molecules190914809","volume":"19","author":"MD Alt\u0131ntop","year":"2014","unstructured":"Alt\u0131ntop MD, \u00d6zdemir A, Turan-Zitouni G, Ilg\u0131n S, Atl\u0131 \u00d6, Demirci F, Kaplanc\u0131kl\u0131 ZA (2014) Synthesis and in vitro evaluation of new nitro-substituted thiazolyl hydrazone derivatives as anticandidal and anticancer agents. Molecules 19(9):14809\u201314820. https:\/\/doi.org\/10.3390\/molecules190914809","journal-title":"Molecules"},{"key":"9776_CR144","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ejmech.2018.03.083","volume":"151","author":"CI Lino","year":"2018","unstructured":"Lino CI, Gon\u00e7alves de Souza I, Borelli BM, Silv\u00e9rio Matos TT, Santos Teixeira IN, Ramos JP, de Souza Maria, Fagundes E, de Oliveira Fernandes P, Maltarollo VG, Johann S, de Oliveira RB (2018) Synthesis, molecular modeling studies and evaluation of antifungal activity of a novel series of thiazole derivatives. Eur J Med Chem 151:248\u2013260. https:\/\/doi.org\/10.1016\/j.ejmech.2018.03.083","journal-title":"Eur J Med Chem"},{"issue":"2","key":"9776_CR145","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.ejmech.2009.11.008","volume":"45","author":"SK Bharti","year":"2010","unstructured":"Bharti SK, Nath G, Tilak R, Singh SK (2010) Synthesis, anti-bacterial and anti-fungal activities of some novel Schiff bases containing 2,4-disubstituted thiazole ring. Eur J Med Chem 45(2):651\u2013660. https:\/\/doi.org\/10.1016\/j.ejmech.2009.11.008","journal-title":"Eur J Med Chem"},{"issue":"12","key":"9776_CR146","doi-asserted-by":"publisher","first-page":"e0145053","DOI":"10.1371\/journal.pone.0145053","volume":"10","author":"A Ahmad","year":"2015","unstructured":"Ahmad A, Wani MY, Khan A, Manzoor N, Molepo J (2015) Synergistic Interactions of Eugenol-tosylate and Its Congeners with Fluconazole against Candida albicans. PloS One 10(12):e0145053. https:\/\/doi.org\/10.1371\/journal.pone.0145053","journal-title":"PloS One"},{"issue":"1","key":"9776_CR147","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/s41598-020-58256-4","volume":"10","author":"SA Lone","year":"2020","unstructured":"Lone SA, Wani MY, Fru P, Ahmad A (2020) Cellular apoptosis and necrosis as therapeutic targets for novel Eugenol Tosylate Congeners against Candida albicans. Sci Rep 10(1):1191. https:\/\/doi.org\/10.1038\/s41598-020-58256-4","journal-title":"Sci Rep"},{"issue":"1","key":"9776_CR148","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/cbdd.12625","volume":"87","author":"TB de Souza","year":"2016","unstructured":"de Souza TB, Brito KM, Silva NC, Rocha RP, de Sousa GF, Duarte LP, Coelho LF, Dias AL, Veloso MP, Carvalho DT, Dias DF (2016) New eugenol glucoside-based derivative shows fungistatic and fungicidal activity against opportunistic Candida glabrata. Chem Biol Drug Des 87(1):83\u201390. https:\/\/doi.org\/10.1111\/cbdd.12625","journal-title":"Chem Biol Drug Des"},{"issue":"2","key":"9776_CR149","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1111\/cbdd.13318","volume":"92","author":"T Hip\u00f3lito","year":"2018","unstructured":"Hip\u00f3lito T, Bastos G, Barbosa T, de Souza TB, Coelho L, Dias A, Rodr\u00edguez IC, Dos Santos MH, Dias DF, Franco LL, Carvalho DT (2018) Synthesis, activity, and docking studies of eugenol-based glucosides as new agents against Candida sp. Chem Biol Drug Des 92(2):1514\u20131524. https:\/\/doi.org\/10.1111\/cbdd.13318","journal-title":"Chem Biol Drug Des"},{"key":"9776_CR150","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12866-014-0201-y","volume":"14","author":"LF Reis de S\u00e1","year":"2014","unstructured":"Reis de S\u00e1 LF, Toledo FT, de Sousa BA, Gon\u00e7alves AC, Tessis AC, Wendler EP, Comasseto JV, Dos Santos AA, Ferreira-Pereira A (2014) Synthetic organotelluride compounds induce the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisiae. BMC Microbiol 14:201. https:\/\/doi.org\/10.1186\/s12866-014-0201-y","journal-title":"BMC Microbiol"},{"issue":"1","key":"9776_CR151","doi-asserted-by":"publisher","first-page":"e01231","DOI":"10.1128\/AAC.01231-16","volume":"61","author":"LF Reis de S\u00e1","year":"2016","unstructured":"Reis de S\u00e1 LF, Toledo FT, Gon\u00e7alves AC, Sousa BA, Dos Santos AA, Brasil PF, Duarte da Silva VA, Tessis AC, Ramos JA, Carvalho MA, Lamping E, Ferreira-Pereira A (2016) Synthetic Organotellurium compounds sensitize drug-resistant Candida albicans clinical isolates to fluconazole. Antimicrob Agents Chemother 61(1):e01231-16. https:\/\/doi.org\/10.1128\/AAC.01231-16","journal-title":"Antimicrob Agents Chemother"},{"key":"9776_CR152","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.2147\/IJN.S151285","volume":"13","author":"HH Lara","year":"2018","unstructured":"Lara HH, Guisbiers G, Mendoza J, Mimun LC, Vincent BA, Lopez-Ribot JL, Nash KL (2018) Synergistic antifungal effect of chitosan-stabilized selenium nanoparticles synthesized by pulsed laser ablation in liquids against Candida albicans biofilms. Int J Nanomedicine 13:2697\u20132708. https:\/\/doi.org\/10.2147\/IJN.S151285","journal-title":"Int J Nanomedicine"},{"key":"9776_CR153","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10876-019-01629-1","volume":"31","author":"GS El-Sayyad","year":"2020","unstructured":"El-Sayyad GS, Mosallam FM, El-Sayed SS, El-Batal AI (2020) Facile biosynthesis of tellurium dioxide nanoparticles by Streptomyces cyaneus melanin pigment and gamma radiation for repressing some Aspergillus pathogens and bacterial wound cultures. J Clust Sci 31:147\u2013159. https:\/\/doi.org\/10.1007\/s10876-019-01629-1","journal-title":"J Clust Sci"},{"key":"9776_CR154","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ijbiomac.2019.10.002","volume":"143","author":"SH Wang","year":"2020","unstructured":"Wang SH, Chen CC, Lee CH, Chen XA, Chang TY, Cheng YC, Young JJ, Lu JJ (2020) Fungicidal and anti-biofilm activities of trimethylchitosan-stabilized silver nanoparticles against Candida species in zebrafish embryos. Int J Biol Macromol 143:724\u2013731. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.10.002","journal-title":"Int J Biol Macromol"},{"issue":"19","key":"9776_CR155","doi-asserted-by":"publisher","first-page":"21183","DOI":"10.1021\/acsami.9b20708","volume":"12","author":"HH Lar","year":"2020","unstructured":"Lar HH, Ixtepan-Turrent L, Jose Yacaman M, Lopez-Ribot J (2020) Inhibition of Candida auris biofilm formation on medical and environmental surfaces by silver nanoparticles. ACS Appl Mater Interfaces 12(19):21183\u201321191. https:\/\/doi.org\/10.1021\/acsami.9b20708","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"9776_CR156","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13568-015-0162-z","volume":"5","author":"N Harrasser","year":"2015","unstructured":"Harrasser N, J\u00fcssen S, Banke IJ, Kmeth R, von Eisenhart-Rothe R, Stritzker B, Gollwitzer H, Burgkart R (2015) Antibacterial efficacy of titanium-containing alloy with silver-nanoparticles enriched diamond-like carbon coatings. AMB Express 5(1):77. https:\/\/doi.org\/10.1186\/s13568-015-0162-z","journal-title":"AMB Express"},{"issue":"57","key":"9776_CR157","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1098\/rsif.2010.0366","volume":"8","author":"X Lu","year":"2011","unstructured":"Lu X, Zhang B, Wang Y, Zhou X, Weng J, Qu S, Feng B, Watari F, Ding Y, Leng Y (2011) Nano-Ag-loaded hydroxyapatite coatings on titanium surfaces by electrochemical deposition. J R Soc Interface 8(57):529\u2013539. https:\/\/doi.org\/10.1098\/rsif.2010.0366","journal-title":"J R Soc Interface"},{"issue":"1","key":"9776_CR158","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/08927014.2020.1715371","volume":"36","author":"AR Padmavathi","year":"2020","unstructured":"Padmavathi AR, Murthy PS, Das A, Priya A, Sushmitha TJ, Pandian SK, Toleti SR (2020) Impediment to growth and yeast-to-hyphae transition in Candida albicans by copper oxide nanoparticles. Biofouling 36(1):56\u201372. https:\/\/doi.org\/10.1080\/08927014.2020.1715371","journal-title":"Biofouling"},{"issue":"12","key":"9776_CR159","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2174\/1381612033455189","volume":"9","author":"UK Buchwald","year":"2003","unstructured":"Buchwald UK, Pirofski L (2003) Immune therapy for infectious diseases at the dawn of the 21st century: the past, present and future role of antibody therapy, therapeutic vaccination and biological response modifiers. Curr Pharm Des 9(12):945\u2013968. https:\/\/doi.org\/10.2174\/1381612033455189","journal-title":"Curr Pharm Des"},{"issue":"5744","key":"9776_CR160","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1126\/science.1119321","volume":"309","author":"J Heitman","year":"2005","unstructured":"Heitman J (2005) Cell biology. A fungal Achilles\u2019 heel. Science 309(5744):2175\u20132176. https:\/\/doi.org\/10.1126\/science.1119321","journal-title":"A fungal Achilles\u2019 heel. Science"},{"key":"9776_CR161","doi-asserted-by":"publisher","first-page":"403121","DOI":"10.1155\/2013\/403121","volume":"2013","author":"F Bugli","year":"2013","unstructured":"Bugli F, Cacaci M, Martini C, Torelli R, Posteraro B, Sanguinetti M, Paroni Sterbini F (2013) Human monoclonal antibody-based therapy in the treatment of invasive candidiasis. Clin Dev Immunol 2013:403121. https:\/\/doi.org\/10.1155\/2013\/403121","journal-title":"Clin Dev Immunol"},{"key":"9776_CR162","doi-asserted-by":"publisher","first-page":"4614183","DOI":"10.1155\/2017\/4614183","volume":"2017","author":"X Liu","year":"2017","unstructured":"Liu X, Ma Z, Zhang J, Yang L (2017) Antifungal compounds against Candida infections from traditional Chinese medicine. Biomed Res Int 2017:4614183. https:\/\/doi.org\/10.1155\/2017\/4614183","journal-title":"Biomed Res Int"},{"issue":"3","key":"9776_CR163","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/jof3030046","volume":"3","author":"M Bondaryk","year":"2017","unstructured":"Bondaryk M, Staniszewska M, Zieli\u0144ska P, Urba\u0144czyk-Lipkowska Z (2017) Natural antimicrobial peptides as inspiration for design of a new generation antifungal compounds. J Fungi (Basel) 3(3):46. https:\/\/doi.org\/10.3390\/jof3030046","journal-title":"J Fungi (Basel)"},{"issue":"19","key":"9776_CR164","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1007\/s00018-013-1260-1","volume":"70","author":"NL Vander Weerden","year":"2013","unstructured":"Vander Weerden NL, Bleackley MR, Anderson MA (2013) Properties and mechanisms of action of naturally occurring antifungal peptides. Cell Mol Life Sci 70(19):3545\u20133570. https:\/\/doi.org\/10.1007\/s00018-013-1260-1","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"9776_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.43.1.1","volume":"43","author":"AJ De Lucca","year":"1999","unstructured":"De Lucca AJ, Walsh TJ (1999) Antifungal peptides: novel therapeutic compounds against emerging pathogens. Antimicrob Agents Chemother 43(1):1\u201311. https:\/\/doi.org\/10.1128\/AAC.43.1.1","journal-title":"Antimicrob Agents Chemother"},{"key":"9776_CR166","doi-asserted-by":"publisher","unstructured":"Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11(8):506\u2013514. https:\/\/doi.org\/10.1038\/nrgastro.2014.66","DOI":"10.1038\/nrgastro.2014.66"},{"issue":"4","key":"9776_CR167","doi-asserted-by":"publisher","first-page":"S203","DOI":"10.1017\/S0007114500006036","volume":"80","author":"BR Goldin","year":"1998","unstructured":"Goldin BR (1998) Health benefits of probiotics. Br J Nutr 80(4):S203-207. https:\/\/doi.org\/10.1017\/S0007114500006036","journal-title":"Br J Nutr"},{"issue":"6","key":"9776_CR168","first-page":"329","volume":"22","author":"I Stamatova","year":"2009","unstructured":"Stamatova I, Meurman JH (2009) Probiotics: health benefits in the mouth. Am J Dent 22(6):329\u2013338","journal-title":"Am J Dent"},{"issue":"3","key":"9776_CR169","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jfda.2018.01.002","volume":"26","author":"R George Kerry","year":"2018","unstructured":"George Kerry R, Patra JK, Gouda S, Park Y, Shin HS, Das G (2018) Benefaction of probiotics for human health: A review. J Food Drug Anal 26(3):927\u2013939. https:\/\/doi.org\/10.1016\/j.jfda.2018.01.002","journal-title":"J Food Drug Anal"},{"key":"9776_CR170","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.3389\/fmicb.2020.01877","volume":"11","author":"SK Tiwari","year":"2020","unstructured":"Tiwari SK, Dicks L, Popov IV, Karaseva A, Ermakov AM, Suvorov A, Tagg JR, Weeks R, Chikindas ML (2020) Probiotics at war against viruses: what is missing from the picture? Front Microbiol 11:1877. https:\/\/doi.org\/10.3389\/fmicb.2020.01877","journal-title":"Front Microbiol"},{"issue":"3","key":"9776_CR171","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0168-1656(00)00375-8","volume":"84","author":"M Saarela","year":"2000","unstructured":"Saarela M, Mogensen G, Fond\u00e9n R, M\u00e4tt\u00f6 J, Mattila-Sandholm T (2000) Probiotic bacteria: safety, functional and technological properties. J Biotechnol 84(3):197\u2013215. https:\/\/doi.org\/10.1016\/s0168-1656(00)00375-8","journal-title":"J Biotechnol"},{"issue":"4","key":"9776_CR172","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1128\/cmr.16.4.658-672.2003","volume":"16","author":"G Reid","year":"2003","unstructured":"Reid G, Jass J, Sebulsky MT, McCormick JK (2003) Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16(4):658\u2013672. https:\/\/doi.org\/10.1128\/cmr.16.4.658-672.2003","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"9776_CR173","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.fm.2010.03.007","volume":"28","author":"SM Cutting","year":"2011","unstructured":"Cutting SM (2011) Bacillus probiotics. Food Microbiol 28(2):214\u2013220. https:\/\/doi.org\/10.1016\/j.fm.2010.03.007","journal-title":"Food Microbiol"},{"key":"9776_CR174","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.archoralbio.2019.01.006","volume":"99","author":"H Kim","year":"2019","unstructured":"Kim H, Kang SS (2019) Antifungal activities against Candida albicans, of cell-free supernatants obtained from probiotic Pediococcus acidilactici HW01. Arch Oral Biol 99:113\u2013119. https:\/\/doi.org\/10.1016\/j.archoralbio.2019.01.006","journal-title":"Arch Oral Biol"},{"key":"9776_CR175","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.mimet.2019.05.001","volume":"162","author":"JC Kosgey","year":"2019","unstructured":"Kosgey JC, Jia L, Fang Y, Yang J, Gao L, Wang J, Nyamao R, Cheteu M, Tong D, Wekesa V, Vasilyeva N, Zhang F (2019) Probiotics as antifungal agents: experimental confirmation and future prospects. J Microbiol Methods 162:28\u201337. https:\/\/doi.org\/10.1016\/j.mimet.2019.05.001","journal-title":"J Microbiol Methods"},{"issue":"10","key":"9776_CR176","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1128\/IAI.65.10.4165-4172.1997","volume":"65","author":"RD Wagner","year":"1997","unstructured":"Wagner RD, Pierson C, Warner T, Dohnalek M, Farmer J, Roberts L, Hilty M, Balish E (1997) Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice. Infect Immun 65(10):4165\u20134172. https:\/\/doi.org\/10.1128\/IAI.65.10.4165-4172.1997","journal-title":"Infect Immun"},{"issue":"7","key":"9776_CR177","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1128\/AEM.07055-11","volume":"78","author":"SA Ishijima","year":"2012","unstructured":"Ishijima SA, Hayama K, Burton JP, Reid G, Okada M, Matsushita Y, Abe S (2012) Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model. Appl Environ Microbiol 78(7):2190\u20132199. https:\/\/doi.org\/10.1128\/AEM.07055-11","journal-title":"Appl Environ Microbiol"},{"key":"9776_CR178","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3389\/fmicb.2019.01033","volume":"10","author":"T Li","year":"2019","unstructured":"Li T, Liu Z, Zhang X, Chen X, Wang S (2019) Local probiotic Lactobacillus crispatus and Lactobacillus delbrueckii exhibit strong antifungal effects against vulvovaginal candidiasis in a rat model. Front Microbiol 10:1033. https:\/\/doi.org\/10.3389\/fmicb.2019.01033","journal-title":"Front Microbiol"},{"key":"9776_CR179","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2016.11.019","volume":"62","author":"EG Severance","year":"2017","unstructured":"Severance EG, Gressitt KL, Stallings CR, Katsafanas E, Schweinfurth LA, Savage C, Adamos MB, Sweeney KM, Origoni AE, Khushalani S, Dickerson FB, Yolken RH (2017) Probiotic normalization of Candida albicans in schizophrenia: a randomized, placebo-controlled, longitudinal pilot study. Brain Behav Immun 62:41\u201345. https:\/\/doi.org\/10.1016\/j.bbi.2016.11.019","journal-title":"Brain Behav Immun"},{"issue":"2","key":"9776_CR180","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/jac\/dkl246","volume":"58","author":"ME Falagas","year":"2006","unstructured":"Falagas ME, Betsi GI, Athanasiou S (2006) Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother 58(2):266\u2013272. https:\/\/doi.org\/10.1093\/jac\/dkl246","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"9776_CR181","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12905-019-0723-4","volume":"19","author":"L Buggio","year":"2019","unstructured":"Buggio L, Somigliana E, Borghi A, Vercellini P (2019) Probiotics and vaginal microecology: fact or fancy? BMC Womens Health 19(1):25. https:\/\/doi.org\/10.1186\/s12905-019-0723-4","journal-title":"BMC Womens Health"},{"key":"9776_CR182","unstructured":"Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C (2019) Are probiotics safe? Bifidobacterium bacteremia in a child with severe heart failure. Infez Med 27(2):175\u2013178. https:\/\/www.infezmed.it\/media\/journal\/Vol_27_2_2019_9.pdf"},{"issue":"3","key":"9776_CR183","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/myc.12021","volume":"56","author":"S Kumar","year":"2013","unstructured":"Kumar S, Singhi S (2013) Role of probiotics in prevention of Candida infection in critically ill children. Mycoses 56(3):204\u2013211. https:\/\/doi.org\/10.1111\/myc.12021","journal-title":"Mycoses"},{"key":"9776_CR184","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3389\/fmicb.2017.01490","volume":"8","author":"F Elshaghabee","year":"2017","unstructured":"Elshaghabee F, Rokana N, Gulhane RD, Sharma C, Panwar H (2017) Bacillus as potential probiotics: status, concerns, and future perspectives. Front Microbiol 8:1490. https:\/\/doi.org\/10.3389\/fmicb.2017.01490","journal-title":"Front Microbiol"},{"issue":"2","key":"9776_CR185","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1159\/000342079","volume":"61","author":"M Bermudez-Brito","year":"2012","unstructured":"Bermudez-Brito M, Plaza-D\u00edaz J, Mu\u00f1oz-Quezada S, G\u00f3mez-Llorente C, Gil A (2012) Probiotic mechanisms of action. Ann Nutr Metab 61(2):160\u2013174. https:\/\/doi.org\/10.1159\/000342079","journal-title":"Ann Nutr Metab"},{"key":"9776_CR186","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131220","author":"C Parolin","year":"2015","unstructured":"Parolin C, Marangoni A, Laghi L, Foschi C, \u00d1ahui Palomino RA, Calonghi N, Cevenini R, Vitali B (2015) Isolation of vaginal lactobacilli and characterization of anti-Candida activity. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0131220","journal-title":"PLoS One"},{"issue":"8","key":"9776_CR187","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/j.1567-1364.2007.00276.x","volume":"7","author":"G Simonetti","year":"2007","unstructured":"Simonetti G, Passariello C, Rotili D, Mai A, Garaci E, Palamara AT (2007) Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans. FEMS Yeast Res 7(8):1371\u20131380. https:\/\/doi.org\/10.1111\/j.1567-1364.2007.00276.x","journal-title":"FEMS Yeast Res"},{"key":"9776_CR188","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ejogrb.2018.07.005","volume":"228","author":"CH Kang","year":"2018","unstructured":"Kang CH, Kim Y, Han SH, Kim JS, Paek NS, So JS (2018) In vitro probiotic properties of vaginal Lactobacillus fermentum MG901 and Lactobacillus plantarum MG989 against Candida albicans. Eur J Obstet Gynecol Reprod Biol 228:232\u2013237. https:\/\/doi.org\/10.1016\/j.ejogrb.2018.07.005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"9776_CR189","doi-asserted-by":"publisher","unstructured":"Itapary Dos Santos C, Ramos Fran\u00e7a Y, Duarte Lima Campos C, Quaresma Bomfim MR, Oliveira Melo B, Assun\u00e7\u00e3o Holanda R, Santos VL, Gomes Monteiro S, Buozzi Moffa E, Souza Monteiro A, Andrade Monteiro C, Monteiro-Neto V (2019) Antifungal and antivirulence activity of vaginal Lactobacillus spp. products against Candida vaginal isolates. Pathogens 8(3):150.\u00a0https:\/\/doi.org\/10.3390\/pathogens8030150","DOI":"10.3390\/pathogens8030150"},{"key":"9776_CR190","doi-asserted-by":"publisher","unstructured":"Ribeiro FC, Rossoni RD, de Barros PP, Santos JD, Fugisaki L, Le\u00e3o M, Junqueira JC (2020) Action mechanisms of probiotics on Candida spp. and candidiasis prevention: an update. J Appl Microbiol 129(2):175\u2013185. https:\/\/doi.org\/10.1111\/jam.14511","DOI":"10.1111\/jam.14511"},{"key":"9776_CR191","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.earlhumdev.2019.05.010","volume":"135","author":"K Halloran","year":"2019","unstructured":"Halloran K, Underwood MA (2019) Probiotic mechanisms of action. Early Hum Dev 135:58\u201365. https:\/\/doi.org\/10.1016\/j.earlhumdev.2019.05.010","journal-title":"Early Hum Dev"},{"issue":"3","key":"9776_CR192","doi-asserted-by":"publisher","first-page":"e0173332","DOI":"10.1371\/journal.pone.0173332","volume":"12","author":"RD Rossoni","year":"2017","unstructured":"Rossoni RD, Fuchs BB, de Barros PP, Velloso MD, Jorge AO, Junqueira JC, Mylonakis E (2017) Lactobacillus paracasei modulates the immune system of Galleria mellonella and protects against Candida albicans infection. PloS One 12(3):e0173332. https:\/\/doi.org\/10.1371\/journal.pone.0173332","journal-title":"PloS One"},{"issue":"6","key":"9776_CR193","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1348-0421.2011.00334.x","volume":"55","author":"J Villena","year":"2011","unstructured":"Villena J, Salva S, Ag\u00fcero G, Alvarez S (2011) Immunomodulatory and protective effect of probiotic Lactobacillus casei against Candida albicans infection in malnourished mice. Microbiol Immunol 55(6):434\u2013445. https:\/\/doi.org\/10.1111\/j.1348-0421.2011.00334.x","journal-title":"Microbiol Immunol"},{"issue":"3","key":"9776_CR194","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4103\/0366-6999.198927","volume":"130","author":"XX Niu","year":"2017","unstructured":"Niu XX, Li T, Zhang X, Wang SX, Liu ZH (2017) Lactobacillus crispatus modulates vaginal epithelial cell innate response to Candida albicans. Chin Med J (Engl) 130(3):273\u2013279. https:\/\/doi.org\/10.4103\/0366-6999.198927","journal-title":"Chin Med J (Engl)"},{"issue":"9","key":"9776_CR195","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","volume":"109","author":"K Fischer","year":"2007","unstructured":"Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, Gottfried E, Schwarz S, Rothe G, Hoves S, Renner K, Timischl B, Mackensen A, Kunz-Schughart L, Andreesen R, Krause SW, Kreutz M (2007) Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109(9):3812\u20133819. https:\/\/doi.org\/10.1182\/blood-2006-07-035972","journal-title":"Blood"},{"issue":"7519","key":"9776_CR196","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature13490","volume":"513","author":"OR Colegio","year":"2014","unstructured":"Colegio OR, Chu NQ, Szabo AL, Chu T, Rhebergen AM, Jairam V, Cyrus N, Brokowski CE, Eisenbarth SC, Phillips GM, Cline GW, Phillips AJ, Medzhitov R (2014) Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513(7519):559\u2013563. https:\/\/doi.org\/10.1038\/nature13490","journal-title":"Nature"},{"issue":"1\u20132","key":"9776_CR197","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.imlet.2013.08.013","volume":"156","author":"A Rizzo","year":"2013","unstructured":"Rizzo A, Losacco A, Carratelli CR (2013) Lactobacillus crispatus modulates epithelial cell defense against Candida albicans through Toll-like receptors 2 and 4, interleukin 8 and human \u03b2-defensins 2 and 3. Immunol Lett 156(1\u20132):102\u2013109. https:\/\/doi.org\/10.1016\/j.imlet.2013.08.013","journal-title":"Immunol Lett"},{"key":"9776_CR198","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.3389\/fmicb.2017.02280","volume":"8","author":"VH Matsubara","year":"2017","unstructured":"Matsubara VH, Ishikawa KH, Ando-Suguimoto ES, Bueno-Silva B, Nakamae A, Mayer M (2017) Probiotic bacteria alter pattern-recognition receptor expression and cytokine profile in a human macrophage model challenged with Candida albicans and lipopolysaccharide. Front Microbiol 8:2280. https:\/\/doi.org\/10.3389\/fmicb.2017.02280","journal-title":"Front Microbiol"},{"issue":"7","key":"9776_CR199","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1007\/s00253-016-7343-9","volume":"100","author":"P Alvarez-Sieiro","year":"2016","unstructured":"Alvarez-Sieiro P, Montalb\u00e1n-L\u00f3pez M, Mu D, Kuipers OP (2016) Bacteriocins of lactic acid bacteria: extending the family. Appl Microbiol Biotechnol 100(7):2939\u20132951. https:\/\/doi.org\/10.1007\/s00253-016-7343-9","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"9776_CR200","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0168-1605(01)00560-8","volume":"71","author":"J Cleveland","year":"2001","unstructured":"Cleveland J, Montville TJ, Nes IF, Chikindas ML (2001) Bacteriocins: safe, natural antimicrobials for food preservation. Int J Food Microbiol 71(1):1\u201320. https:\/\/doi.org\/10.1016\/s0168-1605(01)00560-8","journal-title":"Int J Food Microbiol"},{"key":"9776_CR201","doi-asserted-by":"publisher","unstructured":"Indira M, Venkateswarulu TC, Abraham Peele K, Nazneen Bobby M, Krupanidhi S (2019) Bioactive molecules of probiotic bacteria and their mechanism of action: a review. 3 Biotech 9(8):306. https:\/\/doi.org\/10.1007\/s13205-019-1841-2","DOI":"10.1007\/s13205-019-1841-2"},{"issue":"6","key":"9776_CR202","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1128\/AEM.57.6.1683-1688.1991","volume":"57","author":"CB Lewus","year":"1991","unstructured":"Lewus CB, Kaiser A, Montville TJ (1991) Inhibition of food-borne bacterial pathogens by bacteriocins from lactic acid bacteria isolated from meat. Appl Environ Microbiol 57(6):1683\u20131688. https:\/\/doi.org\/10.1128\/AEM.57.6.1683-1688.1991","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"9776_CR203","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.funbio.2013.12.006","volume":"118","author":"A Sharma","year":"2014","unstructured":"Sharma A, Srivastava S (2014) Anti-Candida activity of two-peptide bacteriocins, plantaricins (Pln E\/F and J\/K) and their mode of action. Fungal Biol 118(2):264\u2013275. https:\/\/doi.org\/10.1016\/j.funbio.2013.12.006","journal-title":"Fungal Biol"},{"issue":"5","key":"9776_CR204","doi-asserted-by":"publisher","first-page":"847","DOI":"10.4315\/0362-028x-66.5.847","volume":"66","author":"SE Murinda","year":"2003","unstructured":"Murinda SE, Rashid KA, Roberts RF (2003) In vitro assessment of the cytotoxicity of nisin, pediocin, and selected colicins on simian virus 40-transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays. J Food Prot 66(5):847\u2013853. https:\/\/doi.org\/10.4315\/0362-028x-66.5.847","journal-title":"J Food Prot"},{"issue":"8","key":"9776_CR205","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1016\/j.biotechadv.2018.10.007","volume":"36","author":"V Juturu","year":"2018","unstructured":"Juturu V, Wu JC (2018) Microbial production of bacteriocins: Latest research development and applications. Biotechnol Adv 36(8):2187\u20132200. https:\/\/doi.org\/10.1016\/j.biotechadv.2018.10.007","journal-title":"Biotechnol Adv"},{"issue":"5","key":"9776_CR206","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1111\/j.1365-2672.2008.03908.x","volume":"105","author":"C Le Lay","year":"2008","unstructured":"Le Lay C, Akerey B, Fliss I, Subirade M, Rouabhia M (2008) Nisin Z inhibits the growth of Candida albicans and its transition from blastospore to hyphal form. J Appl Microbiol 105(5):1630\u20131639. https:\/\/doi.org\/10.1111\/j.1365-2672.2008.03908.x","journal-title":"J Appl Microbiol"},{"issue":"6","key":"9776_CR207","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1208\/s12249-016-0477-3","volume":"17","author":"LC de Abreu","year":"2016","unstructured":"de Abreu LC, Todaro V, Sathler PC, da Silva LC, do Carmo FA, Costa CM, Toma HK, Castro HC, Rodrigues CR, de Sousa VP, Cabral LM, (2016) Development and characterization of nisin nanoparticles as potential alternative for the recurrent vaginal candidiasis treatment. AAPS PharmSciTech 17(6):1421\u20131427. https:\/\/doi.org\/10.1208\/s12249-016-0477-3","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"9776_CR208","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/j.1365-2672.2009.04312.x","volume":"107","author":"B Akerey","year":"2009","unstructured":"Akerey B, Le-Lay C, Fliss I, Subirade M, Rouabhia M (2009) In vitro efficacy of nisin Z against Candida albicans adhesion and transition following contact with normal human gingival cells. J Appl Microbiol 107(4):1298\u20131307. https:\/\/doi.org\/10.1111\/j.1365-2672.2009.04312.x","journal-title":"J Appl Microbiol"},{"issue":"17","key":"9776_CR209","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1073\/pnas.1620432114","volume":"114","author":"CE Graham","year":"2017","unstructured":"Graham CE, Cruz MR, Garsin DA, Lorenz MC (2017) Enterococcus faecalis bacteriocin EntV inhibits hyphal morphogenesis, biofilm formation, and virulence of Candida albicans. Proc Natl Acad Sci U S A 114(17):4507\u20134512. https:\/\/doi.org\/10.1073\/pnas.1620432114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"9776_CR210","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/lam.12037","volume":"56","author":"Y Belguesmia","year":"2013","unstructured":"Belguesmia Y, Choiset Y, Rabesona H, Baudy-Floc\u2019h M, Le Blay G, Haertl\u00e9 T, Chobert JM, (2013) Antifungal properties of durancins isolated from Enterococcus durans A5\u201311 and of its synthetic fragments. Lett Appl Microbiol 56(4):237\u2013244. https:\/\/doi.org\/10.1111\/lam.12037","journal-title":"Lett Appl Microbiol"},{"key":"9776_CR211","doi-asserted-by":"publisher","first-page":"5291486","DOI":"10.1155\/2017\/5291486","volume":"2017","author":"S Ma","year":"2017","unstructured":"Ma S, Ge W, Yan Y, Huang X, Ma L, Li C, Yu S, Chen C (2017) Effects of Streptococcus sanguinis bacteriocin on deformation, adhesion ability, and young\u2019s modulus of Candida albicans. Biomed Res Int 2017:5291486. https:\/\/doi.org\/10.1155\/2017\/5291486","journal-title":"Biomed Res Int"},{"key":"9776_CR212","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41522-018-0053-6","volume":"4","author":"H Mathur","year":"2018","unstructured":"Mathur H, Field D, Rea MC, Cotter PD, Hill C, Ross RP (2018) Fighting biofilms with lantibiotics and other groups of bacteriocins. NPJ Biofilms Microbiomes 4:9. https:\/\/doi.org\/10.1038\/s41522-018-0053-6","journal-title":"NPJ Biofilms Microbiomes"},{"key":"9776_CR213","doi-asserted-by":"publisher","unstructured":"Brown AO, Graham CE, Cruz MR, Singh KV, Murray BE, Lorenz MC, Garsin DA (2019) Antifungal activity of the Enterococcus faecalis peptide entv requires protease cleavage and disulfide bond formation. mBio 10(4):e01334-19. https:\/\/doi.org\/10.1128\/mBio.01334-19","DOI":"10.1128\/mBio.01334-19"},{"key":"9776_CR214","doi-asserted-by":"publisher","first-page":"514152","DOI":"10.1155\/2015\/514152","volume":"2015","author":"S Ma","year":"2015","unstructured":"Ma S, Zhao Y, Xia X, Dong X, Ge W, Li H (2015) Effects of Streptococcus sanguinis bacteriocin on cell surface hydrophobicity, membrane permeability, and ultrastructure of Candida Thallus. Biomed Res Int 2015:514152. https:\/\/doi.org\/10.1155\/2015\/514152","journal-title":"Biomed Res Int"},{"issue":"3","key":"9776_CR215","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1039\/b111145k","volume":"20","author":"D Schwarzer","year":"2003","unstructured":"Schwarzer D, Finking R, Marahiel MA (2003) Nonribosomal peptides: from genes to products. Nat Prod Rep 20(3):275\u2013287. https:\/\/doi.org\/10.1039\/b111145k","journal-title":"Nat Prod Rep"},{"key":"9776_CR216","first-page":"166","volume-title":"Antimicrobial research: Novel bioknowledge and educational programs","author":"S Nayak","year":"2017","unstructured":"Nayak S, Dash B, Mishra BB, Baliyarsingh B (2017) Soil Bacillus\u2014a natural source of antifungal compounds against Candida infection. In: M\u00e9ndez-Vilas A (ed) Antimicrobial research: Novel bioknowledge and educational programs, 6th edn. Formatex Research Center S.L, Spain, pp 166\u2013176","edition":"6"},{"issue":"2","key":"9776_CR217","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.resmic.2008.11.002","volume":"160","author":"HA Hong","year":"2009","unstructured":"Hong HA, Khaneja R, Tam NM, Cazzato A, Tan S, Urdaci M, Brisson A, Gasbarrini A, Barnes I, Cutting SM (2009) Bacillus subtilis isolated from the human gastrointestinal tract. Res Microbiol 160(2):134\u2013143. https:\/\/doi.org\/10.1016\/j.resmic.2008.11.002","journal-title":"Res Microbiol"},{"key":"9776_CR218","unstructured":"Urdaci MC, Pinchuk I (2004) Antimicrobial activity of Bacillus probiotics. In: Ricca E (ed), Henriques AO (ed), Cutting SM (ed) Bacterial spore formers:probiotics and emerging applications. Horizon Bioscience, Norfolk, U.K., pp 171\u2013182"},{"issue":"2","key":"9776_CR219","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4103\/2455-3069.198381","volume":"2","author":"M Suva","year":"2016","unstructured":"Suva M, Sureja V, Kheni D (2016) Novel insight on probiotic Bacillus subtilis: mechanism of action and clinical applications. J Curr Res Sci Med 2(2):65\u201372. https:\/\/doi.org\/10.4103\/2455-3069.198381","journal-title":"J Curr Res Sci Med"},{"issue":"11","key":"9776_CR220","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1007\/s00253-019-09805-z","volume":"103","author":"S Lei","year":"2019","unstructured":"Lei S, Zhao H, Pang B, Qu R, Lian Z, Jiang C, Shao D, Huang Q, Jin M, Shi J (2019) Capability of iturin from Bacillus subtilis to inhibit Candida albicans in vitro and in vivo. Appl Microbiol Biotechnol 103(11):4377\u20134392. https:\/\/doi.org\/10.1007\/s00253-019-09805-z","journal-title":"Appl Microbiol Biotechnol"},{"key":"9776_CR221","doi-asserted-by":"publisher","unstructured":"Nelson J, El-Gendy AO, Mansy MS, Ramadan MA, Aziz RK (2020) The biosurfactants iturin, lichenysin and surfactin, from vaginally isolated lactobacilli, prevent biofilm formation by pathogenic Candida. FEMS Microbiol Lett 367(15):fnaa126. https:\/\/doi.org\/10.1093\/femsle\/fnaa126","DOI":"10.1093\/femsle\/fnaa126"},{"issue":"12","key":"9776_CR222","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s10529-013-1319-y","volume":"35","author":"RS Ye","year":"2013","unstructured":"Ye RS, Zhang ZH, Xu HY, Xu F, Aguilar ZP, Xiong YH, Zeng ZL, Wei H (2013) Differentially-expressed genes in Candida albicans exposed to \u03b5-poly-L-lysine. Biotechnol Lett 35(12):2147\u20132153. https:\/\/doi.org\/10.1007\/s10529-013-1319-y","journal-title":"Biotechnol Lett"},{"key":"9776_CR223","doi-asserted-by":"publisher","unstructured":"Wei L, Yu T, Wang X, Hou J, Wang X, Wang C, Li K, Jing S, Zhang X (2019) In vitro potent activity of \u03b5-poly-L-lysine against Candida albicans and the underlying mechanisms. bioRxiv 605857. https:\/\/doi.org\/10.1101\/605857","DOI":"10.1101\/605857"},{"key":"9776_CR224","unstructured":"Dehghan-Noudeh G, Mohammadreza H, Fazly Bazzaz BS (2005) Isolation, characterization, and investigation of surface and hemolytic activities of a lipopeptide biosurfactant produced by Bacillus subtilis ATCC 6633. J Microbiol 43:272\u2013276. https:\/\/core.ac.uk\/download\/pdf\/162005524.pdf"},{"issue":"1","key":"9776_CR225","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/1082013214565722","volume":"22","author":"YI Hassan","year":"2016","unstructured":"Hassan YI, Zhou T, Bullerman LB (2016) Sourdough lactic acid bacteria as antifungal and mycotoxin-controlling agents. Food Sci Technol Int 22(1):79\u201390. https:\/\/doi.org\/10.1177\/1082013214565722","journal-title":"Food Sci Technol Int"},{"issue":"11","key":"9776_CR226","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.1128\/IAI.72.11.6206-6210.2004","volume":"72","author":"MC Noverr","year":"2004","unstructured":"Noverr MC, Huffnagle GB (2004) Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun 72(11):6206\u20136210. https:\/\/doi.org\/10.1128\/IAI.72.11.6206-6210.2004","journal-title":"Infect Immun"},{"issue":"1","key":"9776_CR227","doi-asserted-by":"publisher","first-page":"8872","DOI":"10.1038\/s41598-019-45467-7","volume":"9","author":"J Guinan","year":"2019","unstructured":"Guinan J, Wang S, Hazbun TR, Yadav H, Thangamani S (2019) Antibiotic-induced decreases in the levels of microbial-derived short-chain fatty acids correlate with increased gastrointestinal colonization of Candida albicans. Sci Rep 9(1):8872. https:\/\/doi.org\/10.1038\/s41598-019-45467-7","journal-title":"Sci Rep"},{"key":"9776_CR228","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.3389\/fmicb.2018.03265","volume":"9","author":"A Louren\u00e7o","year":"2019","unstructured":"Louren\u00e7o A, Pedro NA, Salazar SB, Mira NP (2019) Effect of acetic acid and lactic acid at low ph in growth and azole resistance of Candida albicans and Candida glabrata. Front Microbiol 9:3265. https:\/\/doi.org\/10.3389\/fmicb.2018.03265","journal-title":"Front Microbiol"},{"issue":"10","key":"9776_CR229","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1271\/bbb.70172","volume":"71","author":"S Saegusa","year":"2007","unstructured":"Saegusa S, Totsuka M, Kaminogawa S, Hosoi T (2007) Cytokine responses of intestinal epithelial-like Caco-2 cells to non-pathogenic and opportunistic pathogenic yeasts in the presence of butyric acid. Biosci Biotechnol Biochem 71(10):2428\u20132434. https:\/\/doi.org\/10.1271\/bbb.70172","journal-title":"Biosci Biotechnol Biochem"},{"issue":"9","key":"9776_CR230","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1128\/CVI.00339-14","volume":"21","author":"MT Nieminen","year":"2014","unstructured":"Nieminen MT, Hernandez M, Novak-Frazer L, Kuula H, Ramage G, Bowyer P, Warn P, Sorsa T, Rautemaa R (2014) DL-2-hydroxyisocaproic acid attenuates inflammatory responses in a murine Candida albicans biofilm model. Clin Vaccine Immunol 21(9):1240\u20131245. https:\/\/doi.org\/10.1128\/CVI.00339-14","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"9776_CR231","doi-asserted-by":"publisher","first-page":"e97864","DOI":"10.1371\/journal.pone.0097864","volume":"9","author":"MT Nieminen","year":"2014","unstructured":"Nieminen MT, Novak-Frazer L, Rautemaa V, Rajendran R, Sorsa T, Ramage G, Bowyer P, Rautemaa R (2014) A novel antifungal is active against Candida albicans biofilms and inhibits mutagenic acetaldehyde production in vitro. PloS One 9(5):e97864. https:\/\/doi.org\/10.1371\/journal.pone.0097864","journal-title":"PloS One"},{"issue":"4","key":"9776_CR232","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/myc.12145","volume":"57","author":"M Sakko","year":"2014","unstructured":"Sakko M, Moore C, Novak-Frazer L, Rautemaa V, Sorsa T, Hietala P, J\u00e4rvinen A, Bowyer P, Tj\u00e4derhane L, Rautemaa R (2014) 2-hydroxyisocaproic acid is fungicidal for Candida and Aspergillus species. Mycoses 57(4):214\u2013221. https:\/\/doi.org\/10.1111\/myc.12145","journal-title":"Mycoses"},{"issue":"1","key":"9776_CR233","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1574-695X.2006.00120.x","volume":"48","author":"M Strus","year":"2006","unstructured":"Strus M, Brzychczy-W\u0142och M, Gosiewski T, Kochan P, Heczko PB (2006) The in vitro effect of hydrogen peroxide on vaginal microbial communities. FEMS Immunol Med Microbiol 48(1):56\u201363. https:\/\/doi.org\/10.1111\/j.1574-695X.2006.00120.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"9776_CR234","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.micres.2017.11.002","volume":"207","author":"GA Subramenium","year":"2018","unstructured":"Subramenium GA, Swetha TK, Iyer PM, Balamurugan K, Pandian SK (2018) 5-hydroxymethyl-2-furaldehyde from marine bacterium Bacillus subtilis inhibits biofilm and virulence of Candida albicans. Microbiol Res 207:19\u201332. https:\/\/doi.org\/10.1016\/j.micres.2017.11.002","journal-title":"Microbiol Res"},{"issue":"10","key":"9776_CR235","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1086\/503431","volume":"42","author":"A Casadevall","year":"2006","unstructured":"Casadevall A (2006) The third age of antimicrobial therapy. Clin Infect Dis 42(10):1414\u20131416. https:\/\/doi.org\/10.1086\/503431","journal-title":"Clin Infect Dis"},{"key":"9776_CR236","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fimmu.2017.00022","volume":"8","author":"S Shigemori","year":"2017","unstructured":"Shigemori S, Shimosato T (2017) Applications of genetically modified immunobiotics with high immunoregulatory capacity for treatment of inflammatory bowel diseases. Front Immunol 8:22. https:\/\/doi.org\/10.3389\/fimmu.2017.00022","journal-title":"Front Immunol"},{"key":"9776_CR237","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1472-6750-7-58","volume":"7","author":"A Hultberg","year":"2007","unstructured":"Hultberg A, Tremblay DM, de Haard H, Verrips T, Moineau S, Hammarstr\u00f6m L, Marcotte H (2007) Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages. BMC Biotechnol 7:58. https:\/\/doi.org\/10.1186\/1472-6750-7-58","journal-title":"BMC Biotechnol"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-021-09776-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-021-09776-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-021-09776-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T10:39:11Z","timestamp":1628159951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-021-09776-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":237,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["9776"],"URL":"https:\/\/doi.org\/10.1007\/s12602-021-09776-6","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"9 March 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}